Corrigendum: Neuroendocrinological and Epigenetic Mechanisms Subserving Autonomic Imbalance and HPA Dysfunction in the Metabolic Syndrome (Frontiers in Neuroscience, (2016), 10, (142), 10.3389/fnins.2016.00142);Neuroendorine and Epigentic Mechanisms Subserving Autonomic imbalance and HPA dysfunction in the metabolic syndrome

Frontiers in Neuroscience

Volumn 10, Issue APR, 2016, Pages

  Lemche, Erwin ^a   Chaban, Oleg S ^b   Lemche, Alexandra V ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b BOGOMOLETS NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^c Institute for Clinical Research   (Germany)

Author keywords

Epigenetic programming; Gene regulation; Hypothalamic pituitary adrenocortical axis; Metabolic syndrome; MicroRNA; Pathophysiology; Stress neuropsychobiology; Sympathetic autonomic nervous system.; hypothalamic pituitary adrenocortical axis; stress neuropsychobiology; pathophysiology; epigenetic programming; gene regulation; microRNA; metabolic syndrome; sympathetic autonomic nervous system

Indexed keywords

AGOUTI RELATED PROTEIN; CARBOHYDRATE; GLUCOCORTICOID; HYDROCORTISONE; LEPTIN; MELANOCORTIN; MICRORNA; NEUROPEPTIDE Y; SODIUM;

ADIPOSE TISSUE; APOA1 GENE; APOA4 GENE; APOA5 GENE; APOC3 GENE; ARTICLE; AUTONOMIC DYSFUNCTION; CHRONIC INFLAMMATION; EARLY LIFE STRESS; ENDOTHELIAL DYSFUNCTION; EPIGENETICS; FAT MASS; GENE; GENE CONTROL; GENE EXPRESSION; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE PHOSPHORYLATION; HISTONE UBIQUITINATION; HSD11B1 GENE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIPE GENE; MALNUTRITION; METABOLIC SYNDROME X; NATRIURESIS; NKBF1 GENE; NONHUMAN; OBESITY; OXIDATIVE STRESS; PPARG GENE; TCF7C GENE; TNFA GENE;

EID: 84966372895     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2021.678258     Document Type: Erratum

References (364)

1. Abraham, S. B., Rubino, D., Sinaii, N., Ramsey, S., and Nieman, L. K. (2013). Cortisol, obesity, and the metabolic syndrome: a cross-sectional study of obese subjects and review of the literature. Obesity (Silver Spring) 21, E105-E117. doi: 10.1002/oby.20083
2. Adams, J. N., Raffield, L. M., Freedman, B. I., Langefeld, C. D., Ng, M. C., Carr, J. J., et al. (2014). Analysis of common and coding variants with cardiovascular disease in the Diabetes Heart Study. Cardiovasc. Diabetol. 13:77. doi: 10.1186/1475-2840-13-77
3. Agha, G., Houseman, E. A., Kelsey, K. T., Eaton, C. B., Buka, S. L., and Loucks, E. B. (2015). Adiposity is associated with DNA methylation profile in adipose tissue. Int. J. Epidemiol. 44, 1277-1287. doi: 10.1093/ije/dyu236
4. Albert, J. S., Yerges-Armstrong, L. M., Horenstein, R. B., Pollin, T. I., Sreenivasan, U. T., Chai, S., et al. (2014). Null mutation in hormone-sensitive lipase gene and risk of type 2 diabetes. N. Engl. J. Med. 370, 2307-2315. doi: 10.1056/NEJMoa1315496
5. Alberti, K. G., and Zimmet, P. Z. (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 15, 539-553.
6. Alehagen, U., Vorkapic, E., Ljungberg, L., Länne, T., and Wågsäter, D. (2015). Gender difference in adiponectin associated with cardiovascular mortality. BMC Med. Genet. 16:37. doi: 10.1186/s12881-015-0187-9
7. Ali, A. T., Hochfeld, W. E., Myburgh, R., and Pepper, M. S. (2013). Adipocyte and adipogenesis. Eur. J. Cell Biol. 92, 229-236. doi: 10.1016/j.ejcb.2013.06.001
8. Allard, C., Desgagné, V., Patenaude, J., Lacroix, M., Guillemette, L., Battista, M. C., et al. (2015). Mendelian randomization supports causality between maternal hyperglycemia and epigenetic regulation of leptin gene in newborns. Epigenetics 10, 342-351. doi: 10.1080/15592294.2015.1029700
9. Almadi, T., Cathers, I., and Chow, C. M. (2013). Associations among work-related stress, cortisol, inflammation, and metabolic syndrome. Psychophysiology 50, 821-830. doi: 10.1111/psyp.12069
10. Almén, M. S., Nilsson, E. K., Jacobsson, J. A., Kalnina, I., Klovins, J., Fredriksson, R., et al. (2014). Genome-wide analysis reveals DNA methylation markers that vary with both age and obesity. Gene 548, 61-67. doi: 10.1016/j.gene.2014.07.009
11. Anagnostis, P., Athyros, V. G., Tziomalos, K., Karagiannis, A., and Mikhailidis, D. P. (2009). Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J. Clin. Endocrinol. Metab. 94, 2692-2701. doi: 10.1210/jc.2009-0370
12. Angelucci, F., Gelfo, F., Fiore, M., Croce, N., Mathé, A. A., Bernardini, S., et al. (2014). The effect of neuropeptide Y on cell survival and neurotrophin expression in in-vitro models of Alzheimer's disease. Can. J. Physiol. Pharmacol. 92, 621-630. doi: 10.1139/cjpp-2014-0099
13. Annerbrink, K., Westberg, L., Nilsson, S., Rosmond, R., Holm, G., and Eriksson, E. (2008). Catechol O-methyltransferase val158-met polymorphism is associated with abdominal obesity and blood pressure in men. Metab. Clin. Exp. 57, 708-711. doi: 10.1016/j.metabol.2008.01.012
14. Appleton, A. A., Armstrong, D. A., Lesseur, C., Lee, J., Padbury, J. F., Lester, B. M., et al. (2013). Patterning in placental 11-B hydroxysteroid dehydrogenase methylation according to prenatal socioeconomic adversity. PLoS ONE 8:e74691. doi: 10.1371/journal.pone.0074691
15. Assmann, T. S., Duarte, G. C., Rheinheimer, J., Cruz, L. A., Canani, L. H., and Crispim, D. (2014). The TCF7L2 rs7903146 (C/T) polymorphism is associated with risk to type 2 diabetes mellitus in Southern-Brazil. Arq. Bras. Endocrinol. Metabol. 58, 918-925. doi: 10.1590/0004-2730000003510
16. Atasoy, D., Betley, J. N., Su, H. H., and Sternson, S. M. (2012). Deconstruction of a neural circuit for hunger. Nature 488, 172-177. doi: 10.1038/nature11270
17. Babu, M., Durga Devi, T., Mäkinen, P., Kaikkonen, M., Lesch, H. P., Junttila, S., et al. (2015). Differential promoter methylation of macrophage genes is associated with impaired vascular growth in ischemic muscles of hyperlipidemic and type 2 diabetic mice: genome-wide promoter methylation study. Circ. Res. 117, 289-299. doi: 10.1161/CIRCRESAHA.115.306424
18. Bäckberg, M., Madjid, N., Ögren, S. O., and Meister, B. (2004). Down-regulated expression of agouti-related protein (AGRP) mRNA in the hypothalamic arcuate nucleus of hyperphagic and obese tub/tub mice. Brain Res. Mol. Brain Res. 125, 129-139. doi: 10.1016/j.molbrainres.2004.03.012
19. Balthasar, N. (2006). Genetic dissection of neuronal pathways controlling energy homeostasis. Obesity (Silver Spring) 14(Suppl. 5), 222S-227S. doi: 10.1038/oby.2006.313
20. Balthasar, N., Dalgaard, L. T., Lee, C. E., Yu, J., Funahashi, H., Williams, T., et al. (2005). Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell 123, 493-505. doi: 10.1016/j.cell.2005.08.035
21. Barnes, J. N., Charkoudian, N., Matzek, L. J., Johnson, C. P., Joyner, M. J., and Curry, T. B. (2014). Acute cyclooxygenase inhibition does not alter muscle sympathetic nerve activity or forearm vasodilator responsiveness in lean and obese adults. Physiol. Rep. 2:e12079. doi: 10.14814/phy2.12079
22. Barnes, M. J., and McDougal, D. H. (2014). Leptin into the rostral ventral lateral medulla (RVLM) augments renal sympathetic nerve activity and blood pressure. Front. Neurosci. 8:232. doi: 10.3389/fnins.2014.00232
23. Bartoli, F., Carrà, G., Crocamo, C., Carretta, D., and Clerici, M. (2013). Metabolic syndrome in people suffering from posttraumatic stress disorder: a systematic review and meta-analysis. Metab. Syndr. Relat. Disord. 11, 301-308. doi: 10.1089/met.2013.0010
24. Bassi, M., Furuya, W. I., Zoccal, D. B., Menani, J. V., Colombari, E., Hall, J. E., et al. (2015a). Control of respiratory and cardiovascular functions by leptin. Life Sci. 125, 25-31. doi: 10.1016/j.lfs.2015.01.019
25. Bassi, M., Nakamura, N. B., Furuya, W. I., Colombari, D. S., Menani, J. V., do Carmo, J. M., et al. (2015b). Activation of the brain melanocortin system is required for leptin-induced modulation of chemorespiratory function. Acta Physiol. (Oxf.) 213, 893-901. doi: 10.1111/apha.12394
26. Batterham, R. L., Ffytche, D. H., Rosenthal, J. M., Zelaya, F. O., Barker, G. J., Withers, D. J., et al. (2007). PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature 450, 106-109. doi: 10.1038/nature06212
27. Baudrand, R., Campino, C., Carvajal, C. A., Olivieri, O., Guidi, G., Faccini, G., et al. (2014). High sodium intake is associated with increased glucocorticoid production, insulin resistance and metabolic syndrome. Clin. Endocrinol. (Oxf.) 80, 677-684. doi: 10.1111/cen.12225
28. Bayles, R., Baker, E. K., Jowett, J. B., Barton, D., Esler, M., El-Osta, A., et al. (2013). Methylation of the SLC6a2 gene promoter in major depression and panic disorder. PLoS ONE 8:e83223. doi: 10.1371/journal.pone.0083223
29. Bazzi, M. D., Nasr, F. A., Alanazi, M. S., Alamri, A., Turjoman, A. A., Moustafa, A. S., et al. (2014). Association between FTO, MC4R, SLC30A8, and KCNQ1 gene variants and type 2 diabetes in Saudi population. Genet. Mol. Res. 13, 10194-10203. doi: 10.4238/2014.December.4.14
30. Beavers, K. M., Hsu, F. C., Houston, D. K., Beavers, D. P., Harris, T. B., Hue, T. F., et al. (2013). The role of metabolic syndrome, adiposity, and inflammation in physical performance in the Health ABC Study. J. Gerontol. A Biol. Sci. Med. Sci. 68, 617-623. doi: 10.1093/gerona/gls213
31. Begriche, K., Levasseur, P. R., Zhang, J., Rossi, J., Skorupa, D., Solt, L. A., et al. (2011). Genetic dissection of the functions of the melanocortin-3 receptor, a seven-transmembrane G-protein-coupled receptor, suggests roles for central and peripheral receptors in energy homeostasis. J. Biol. Chem. 286, 40771-40781. doi: 10.1074/jbc. M111.278374
32. Bell, C. G., Finer, S., Lindgren, C. M., Wilson, G. A., Rakyan, V. K., Teschendorff, A. E., et al. (2010). Integrated genetic and epigenetic analysis identifies haplotype-specific methylation in the FTO type 2 diabetes and obesity susceptibility locus. PLoS ONE 5:e14040. doi: 10.1371/journal.pone.0014040
33. Betley, J. N., Xu, S., Cao, Z. F., Gong, R., Magnus, C. J., Yu, Y., et al. (2015). Neurons for hunger and thirst transmit a negative-valence teaching signal. Nature 521, 180-185. doi: 10.1038/nature14416
34. Black, M. H., Wu, J., Takayanagi, M., Wang, N., Taylor, K. D., Haritunians, T., et al. (2015). Variation in PPARG is associated with longitudinal change in insulin resistance in Mexican Americans at risk for type 2 diabetes. J. Clin. Endocrinol. Metab. 100, 1187-1195. doi: 10.1210/jc.2014-3246
35. Bockmühl, Y., Patchev, A. V., Madejska, A., Hoffmann, A., Sousa, J. C., Sousa, N., et al. (2015). Methylation at the CpG island shore region upregulates NR3C1 promoter activity after early-life stress. Epigenetics 10, 247-257. doi: 10.1080/15592294.2015.1017199
36. Bollati, V., Favero, C., Albetti, B., Tarantini, L., Moroni, A., Byun, H. M., et al. (2014). Nutrients intake is associated with DNA methylation of candidate inflammatory genes in a population of obese subjects. Nutrients 6, 4625-4639. doi: 10.3390/nu6104625
37. Brindley, D. N. (1995). Role of glucocorticoids and fatty acids in the impairment of lipid metabolism observed in the metabolic syndrome. Int. J. Obes. Relat. Metab. Disord. 19(Suppl. 1), S69-S75.
38. Brown, M. R., Fisher, L. A., Spiess, J., Rivier, C., Rivier, J., and Vale, W. (1982). Corticotropin-releasing factor: actions on the sympathetic nervous system and metabolism. Endocrinology 111, 928-931. doi: 10.1210/endo-111-3-928
39. Brunner, E. J., Hemingway, H., Walker, B. R., Page, M., Clarke, P., Juneja, M., et al. (2002). Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study. Circulation 106, 2659-2665. doi: 10.1161/01.CIR.0000038364.26310.BD
40. Buchholz, K., Schorr, U., Turan, S., Sharma, A. M., and Deter, H. C. (1999). [Emotional irritability and anxiety in salt-sensitive persons at risk for essential hypertension]. Psychother. Psychosom. Med. Psychol. 49, 284-289.
41. Buijs, R. M., and Kreier, F. (2006). The metabolic syndrome: a brain disease? J. Neuroendocrinol. 18, 715-716. doi: 10.1111/j.1365-2826.2006.01456.x
42. Bulatova, I. A., Shchekotova, A. P., Krivtsov, A. V., Shchekotov, V. V., Nasibullina, N. I., Suzdal'tseva, K. N., et al. (2015). [Metabolic disorder and polymorphism of the genes encoding for beta-2-adrenergic receptor and apolipoproteins B in chronic hepatitis C and non-alcoholic fatty liver diseases]. Klin. Med. (Mosk) 93, 35-41.
43. Burguete-Garcia, A. I., Martinez-Nava, G. A., Valladares-Salgado, A., Bermudez Morales, V. H., Estrada-Velasco, B., Wacher, N., et al. (2014). Association of beta1 and beta3 adrenergic receptors gene polymorphisms with insulin resistance and high lipid profiles related to type 2 diabetes and metabolic syndrome. Nutr. Hosp. 29, 1327-1334. doi: 10.3305/nh.2014.29.6.7367
44. Caballero, B. (2007). The global epidemic of obesity: an overview. Epidemiol. Rev. 29, 1-5. doi: 10.1093/epirev/mxm012
45. Capoulade, R., Clavel, M. A., Dumesnil, J. G., Chan, K. L., Teo, K. K., Tam, J. W., et al. (2012). Impact of metabolic syndrome on progression of aortic stenosis: influence of age and statin therapy. J. Am. Coll. Cardiol. 60, 216-223. doi: 10.1016/j.jacc.2012.03.052
46. Carvalheira, J. B., Odegaard, J. I., and Chawla, A. (2014). A new role for the brain in metabolic control. Nat. Med. 20, 472-473. doi: 10.1038/nm.3556
47. Cassaglia, P. A., Hermes, S. M., Aicher, S. A., and Brooks, V. L. (2011). Insulin acts in the arcuate nucleus to increase lumbar sympathetic nerve activity and baroreflex function in rats. J. Physiol. 589(Pt 7), 1643-1662. doi: 10.1113/jphysiol.2011.205575
48. Caussy, C., Charrière, S., Marçais, C., Di Filippo, M., Sassolas, A., Delay, M., et al. (2014). An APOA5 3' UTR variant associated with plasma triglycerides triggers APOA5 downregulation by creating a functional miR-485-5p binding site. Am. J. Hum. Genet. 94, 129-134. doi: 10.1016/j.ajhg.2013.12.001
49. Cavadas, C., Silva, A. P., Mosimann, F., Cotrim, M. D., Ribeiro, C. A., Brunner, H. R., et al. (2001). NPY regulates catecholamine secretion from human adrenal chromaffin cells. J. Clin. Endocrinol. Metab. 86, 5956-5963. doi: 10.1210/jcem.86.12.8091
50. Chambers, J. C., Elliott, P., Zabaneh, D., Zhang, W., Li, Y., Froguel, P., et al. (2008). Common genetic variation near MC4R is associated with waist circumference and insulin resistance. Nat. Genet. 40, 716-718. doi: 10.1038/ng.156
51. Chandola, T., Britton, A., Brunner, E., Hemingway, H., Malik, M., Kumari, M., et al. (2008). Work stress and coronary heart disease: what are the mechanisms? Eur. Heart J. 29, 640-648. doi: 10.1093/eurheartj/ehm584
52. Chandola, T., Brunner, E., and Marmot, M. (2006). Chronic stress at work and the metabolic syndrome: prospective study. BMJ 332, 521-525. doi: 10.1136/bmj.38693.435301.80
53. Chang, L., and Neu, J. (2015). Early factors leading to later obesity: interactions of the microbiome, epigenome, and nutrition. Curr. Probl. Pediatr. Adolesc. Health Care 45, 134-142. doi: 10.1016/j.cppeds.2015.03.003
54. Chen, K., and Rajewsky, N. (2007). The evolution of gene regulation by transcription factors and microRNAs. Nat. Rev. Genet. 8, 93-103. doi: 10.1038/nrg1990
55. Chen, L., Dai, Y. M., Ji, C. B., Yang, L., Shi, C. M., Xu, G. F., et al. (2014). MiR-146b is a regulator of human visceral preadipocyte proliferation and differentiation and its expression is altered in human obesity. Mol. Cell. Endocrinol. 393, 65-74. doi: 10.1016/j.mce.2014.05.022
56. Chen, Y. W., Harris, R. A., Hatahet, Z., and Chou, K. M. (2015). Ablation of XP-V gene causes adipose tissue senescence and metabolic abnormalities. Proc. Natl. Acad. Sci. U.S.A. 112, E4556-E4564. doi: 10.1073/pnas.1506954112
57. Cifani, C., Micioni Di Bonaventura, M. V., Pucci, M., Giusepponi, M. E., Romano, A., Di Francesco, A., et al. (2015). Regulation of hypothalamic neuropeptides gene expression in diet induced obesity resistant rats: possible targets for obesity prediction? Front. Neurosci. 9:187. doi: 10.3389/fnins.2015.00187
58. Clément, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., et al. (1998). A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392, 398-401. doi: 10.1038/32911
59. Cole, C. B., Nikpay, M., Lau, P., Stewart, A. F., Davies, R. W., Wells, G. A., et al. (2014). Adiposity significantly modifies genetic risk for dyslipidemia. J. Lipid Res. 55, 2416-2422. doi: 10.1194/jlr. P052522
60. Cone, R. D. (2005). Anatomy and regulation of the central melanocortin system. Nat. Neurosci. 8, 571-578. doi: 10.1038/nn1455
61. Coupé, B., Amarger, V., Grit, I., Benani, A., and Parnet, P. (2010). Nutritional programming affects hypothalamic organization and early response to leptin. Endocrinology 151, 702-713. doi: 10.1210/en.2009-0893
62. Couturier, C., Sarkis, C., Séron, K., Belouzard, S., Chen, P., Lenain, A., et al. (2007). Silencing of OB-RGRP in mouse hypothalamic arcuate nucleus increases leptin receptor signaling and prevents diet-induced obesity. Proc. Natl. Acad. Sci. U.S.A. 104, 19476-19481. doi: 10.1073/pnas.0706671104
63. Crépin, D., Benomar, Y., Riffault, L., Amine, H., Gertler, A., and Taouis, M. (2014). The over-expression of miR-200a in the hypothalamus of ob/ob mice is linked to leptin and insulin signaling impairment. Mol. Cell. Endocrinol. 384, 1-11. doi: 10.1016/j.mce.2013.12.016
64. Crosby, J., Peloso, G. M., Auer, P. L., Crosslin, D. R., Stitziel, N. O., Lange, L. A., et al. (2014). Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N. Engl. J. Med. 371, 22-31. doi: 10.1056/NEJMoa1307095
65. Curry, T. B., Hines, C. N., Barnes, J. N., Somaraju, M., Basu, R., Miles, J. M., et al. (2014). Relationship of muscle sympathetic nerve activity to insulin sensitivity. Clin. Auton. Res. 24, 77-85. doi: 10.1007/s10286-014-0235-0
66. Cyphert, T. J., Morris, R. T., House, L. M., Barnes, T. M., Otero, Y. F., Barham, W. J., et al. (2015). NF-kappaB-dependent airway inflammation triggers systemic insulin resistance. Am. J. Physiol. Regul. Integr. Comp. Physiol. 309, R1144-R1152. doi: 10.1152/ajpregu.00442.2014
67. da Silva, A. A., do Carmo, J. M., Wang, Z., and Hall, J. E. (2014). The brain melanocortin system, sympathetic control, and obesity hypertension. Physiology (Bethesda) 29, 196-202. doi: 10.1152/physiol.00061.2013
68. da Silva, A. A., Kuo, J. J., Tallam, L. S., Liu, J., and Hall, J. E. (2006). Does obesity induce resistance to the long-term cardiovascular and metabolic actions of melanocortin 3/4 receptor activation? Hypertension 47, 259-264. doi: 10.1161/01.HYP.0000198458.70351.e0
69. Dannenberg, L. O., and Edenberg, H. J. (2006). Epigenetics of gene expression in human hepatoma cells: expression profiling the response to inhibition of DNA methylation and histone deacetylation. BMC Genomics 7:181. doi: 10.1186/1471-2164-7-181
70. Dayeh, T., Volkov, P., Salö, S., Hall, E., Nilsson, E., Olsson, A. H., et al. (2014). Genome-wide DNA methylation analysis of human pancreatic islets from type 2 diabetic and non-diabetic donors identifies candidate genes that influence insulin secretion. PLoS Genet. 10:e1004160. doi: 10.1371/journal.pgen.1004160
71. Dehwah, M. A., Xu, A., and Huang, Q. (2012). MicroRNAs and type 2 diabetes/obesity. J. Genet. Genomics 39, 11-18. doi: 10.1016/j.jgg.2011.11.007
72. Deniz, F., Katircibasi, M. T., Pamukcu, B., Binici, S., and Sanisoglu, S. Y. (2007). Association of metabolic syndrome with impaired heart rate recovery and low exercise capacity in young male adults. Clin. Endocrinol. (Oxf.) 66, 218-223. doi: 10.1111/j.1365-2265.2006.02711.x
73. Derghal, A., Djelloul, M., Airault, C., Pierre, C., Dallaporta, M., Troadec, J. D., et al. (2015). Leptin is required for hypothalamic regulation of miRNAs targeting POMC 3'UTR. Front. Cell. Neurosci. 9:172. doi: 10.3389/fncel.2015.00172
74. Dermitzaki, E., Liapakis, G., Androulidaki, A., Venihaki, M., Melissas, J., Tsatsanis, C., et al. (2014). Corticotrophin-Releasing Factor (CRF) and the urocortins are potent regulators of the inflammatory phenotype of human and mouse white adipocytes and the differentiation of mouse 3T3L1 pre-adipocytes. PLoS ONE 9:e97060. doi: 10.1371/journal.pone.0097060
75. Deter, H. C., Blecher, A., and Weber, C. S. (2007a). Cardiovascular reactivity of patients with essential and renal hypertension in an emotion-triggering interview. Behav. Med. 32, 117-125. doi: 10.3200/BMED.32.4.117-125
76. Deter, H. C., Blum, B., and Schwarz, U. (2002). [Psychophysiological and psychological aspects of mild hypertension]. Psychother. Psychosom. Med. Psychol. 52, 265-274. doi: 10.1055/s-2002-32247
77. Deter, H. C., Klepper, A., and Schulte, K. H. (1996). Preliminary results of a differentiated emotion-stimulating interview in patients with essential hypertension as compared with inpatients of a psychosomatic unit and normal controls. Psychother. Psychosom. 65, 262-271. doi: 10.1159/000289086
78. Deter, H. C., Wolf, C., Blecher, A., Thomas, A., Zimmermann, F., and Weber, C. (2007b). Cardiovascular reactivity in patients with essential or renal hypertension under standardized mental stress. Clin. Exp. Hypertens. 29, 301-310. doi: 10.1080/10641960701500414
79. Dhillo, W. S., Small, C. J., Gardiner, J. V., Bewick, G. A., Whitworth, E. J., Jethwa, P. H., et al. (2003). Agouti-related protein has an inhibitory paracrine role in the rat adrenal gland. Biochem. Biophys. Res. Commun. 301, 102-107. doi: 10.1016/S0006-291X(02)02991-1
80. Díez, J. J., and Iglesias, P. (2003). The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur. J. Endocrinol. 148, 293-300. doi: 10.1530/eje.0.1480293
81. Dik, M. G., Jonker, C., Comijs, H. C., Deeg, D. J., Kok, A., Yaffe, K., et al. (2007). Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care 30, 2655-2660. doi: 10.2337/dc06-1190
82. Dinel, A.-L., André, C., Aubert, A., Ferreira, G., Layé, S., and Castanon, N. (2011). Cognitive and emotional alterations are related to hippocampal inflammation in a mouse model of metabolic syndrome. PLoS ONE 6:e24325. doi: 10.1371/journal.pone.0024325
83. Do, R., Willer, C. J., Schmidt, E. M., Sengupta, S., Gao, C., Peloso, G. M., et al. (2013). Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat. Genet. 45, 1345-1352. doi: 10.1038/ng.2795
84. Douvris, A., Soubeyrand, S., Naing, T., Martinuk, A., Nikpay, M., Williams, A., et al. (2014). Functional analysis of the TRIB1 associated locus linked to plasma triglycerides and coronary artery disease. J. Am. Heart Assoc. 3, e000884. doi: 10.1161/JAHA.114.000884
85. Drogan, D., Boeing, H., Janke, J., Schmitt, B., Zhou, Y., Walter, J., et al. (2015). Regional distribution of body fat in relation to DNA methylation within the LPL, ADIPOQ and PPARgamma promoters in subcutaneous adipose tissue. Nutr. Diabetes 5, e168. doi: 10.1038/nutd.2015.19
86. Dryden, S., Pickavance, L., Frankish, H. M., and Williams, G. (1995). Increased neuropeptide Y secretion in the hypothalamic paraventricular nucleus of obese (fa/fa) Zucker rats. Brain Res. 690, 185-188. doi: 10.1016/0006-8993(95)00628-4
87. Dudchenko, I. A., Pristupa, L. N., Ataman, A. V., and Garbuzova, V. (2014). Genetic dependency of blood pressure and heart rate in patients with arterial hypertension and obesity. Vestn. Ross. Akad. Med. Nauk. 40-46. doi: 10.15690/vramn.v69i5-6.1042
88. Dunn, J., Simmons, R., Thabet, S., and Jo, H. (2015). The role of epigenetics in the endothelial cell shear stress response and atherosclerosis. Int. J. Biochem. Cell Biol. 67, 167-176. doi: 10.1016/j.biocel.2015.05.001
89. Eckel, R. H., Alberti, K. G., Grundy, S. M., and Zimmet, P. Z. (2010). The metabolic syndrome. Lancet 375, 181-183. doi: 10.1016/S0140-6736(09)61794-3
90. Eckel, R. H., Grundy, S. M., and Zimmet, P. Z. (2005). The metabolic syndrome. Lancet 365, 1415-1428. doi: 10.1016/S0140-6736(05)66378-7
91. Edmondson, D., Richardson, S., Falzon, L., Davidson, K. W., Mills, M. A., and Neria, Y. (2012). Posttraumatic stress disorder prevalence and risk of recurrence in acute coronary syndrome patients: a meta-analytic review. PLoS ONE 7:e38915. doi: 10.1371/journal.pone.0038915
92. Ellacott, K. L., Halatchev, I. G., and Cone, R. D. (2006). Interactions between gut peptides and the central melanocortin system in the regulation of energy homeostasis. Peptides 27, 340-349. doi: 10.1016/j.peptides.2005.02.031
93. Emdin, M., Gastaldelli, A., Muscelli, E., Macerata, A., Natali, A., Camastra, S., et al. (2001). Hyperinsulinemia and autonomic nervous system dysfunction in obesity: effects of weight loss. Circulation 103, 513-519. doi: 10.1161/01.CIR.103.4.513
94. Esau, C., Davis, S., Murray, S. F., Yu, X. X., Pandey, S. K., Pear, M., et al. (2006). miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 3, 87-98. doi: 10.1016/j.cmet.2006.01.005
95. Esler, M., Straznicky, N., Eikelis, N., Masuo, K., Lambert, G., and Lambert, E. (2006). Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension 48, 787-796. doi: 10.1161/01.HYP.0000242642.42177.49
96. Fahlbusch, F. B., Ruebner, M., Volkert, G., Offergeld, R., Hartner, A., Menendez-Castro, C., et al. (2012). Corticotropin-releasing hormone stimulates expression of leptin, 11beta-HSD2 and syncytin-1 in primary human trophoblasts. Reprod. Biol. Endocrinol. 10, 80. doi: 10.1186/1477-7827-10-80
97. Fani, L., Bak, S., Delhanty, P., van Rossum, E. F., and van den Akker, E. L. (2014). The melanocortin-4 receptor as target for obesity treatment: a systematic review of emerging pharmacological therapeutic options. Int. J. Obes. (Lond.) 38, 163-169. doi: 10.1038/ijo.2013.80
98. Farmer, A., Korszun, A., Owen, M. J., Craddock, N., Jones, L., Jones, I., et al. (2008). Medical disorders in people with recurrent depression. Br. J. Psychiatry 192, 351-355. doi: 10.1192/bjp.bp.107.038380
99. Farooqi, I. S., Keogh, J. M., Yeo, G. S., Lank, E. J., Cheetham, T., and O'Rahilly, S. (2003a). Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N. Engl. J. Med. 348, 1085-1095. doi: 10.1056/NEJMoa022050
100. Farooqi, I. S., Yeo, G. S., and O'Rahilly, S. (2003b). Binge eating as a phenotype of melanocortin 4 receptor gene mutations. N. Engl. J. Med. 349, 606-609; author reply -9. doi: 10.1056/NEJMoa021971
101. Farzi, A., Reichmann, F., and Holzer, P. (2015). The homeostatic role of neuropeptide Y in immune function and its impact on mood and behaviour. Acta Physiol. (Oxf.) 213, 603-627. doi: 10.1111/apha.12445
102. Fisher, L. A., Rivier, J., Rivier, C., Spiess, J., Vale, W., and Brown, M. R. (1982). Corticotropin-releasing factor (CRF): central effects on mean arterial pressure and heart rate in rats. Endocrinology 110, 2222-2224. doi: 10.1210/endo-110-6-2222
103. Flowers, E., Froelicher, E. S., and Aouizerat, B. E. (2013). MicroRNA regulation of lipid metabolism. Metab. Clin. Exp. 62, 12-20. doi: 10.1016/j.metabol.2012.04.009
104. Ford, E. S., Giles, W. H., and Dietz, W. H. (2002). Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287, 356-359. doi: 10.1001/jama.287.3.356
105. Forsythe, C. E., Phinney, S. D., Fernandez, M. L., Quann, E. E., Wood, R. J., Bibus, D. M., et al. (2008). Comparison of low fat and low carbohydrate diets on circulating fatty acid composition and markers of inflammation. Lipids 43, 65-77. doi: 10.1007/s11745-007-3132-7
106. Fortuño, A., Rodríguez, A., Gómez-Ambrosi, J., Frühbeck, G., and Díez, J. (2003). Adipose tissue as an endocrine organ: role of leptin and adiponectin in the pathogenesis of cardiovascular diseases. J. Physiol. Biochem. 59, 51-60. doi: 10.1007/BF03179868
107. Fossum, E., Høieggen, A., Reims, H. M., Moan, A., Rostrup, M., Eide, I., et al. (2004). High screening blood pressure is related to sympathetic nervous system activity and insulin resistance in healthy young men. Blood Press. 13, 89-94. doi: 10.1080/08037050310031008
108. Friso, S., Pizzolo, F., Choi, S. W., Guarini, P., Castagna, A., Ravagnani, V., et al. (2008). Epigenetic control of 11-beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension. Atherosclerosis 199, 323-327. doi: 10.1016/j.atherosclerosis.2007.11.029
109. Fujiki, K., Kano, F., Shiota, K., and Murata, M. (2009). Expression of the peroxisome proliferator activated receptor gamma gene is repressed by DNA methylation in visceral adipose tissue of mouse models of diabetes. BMC Biol. 7:38. doi: 10.1186/1741-7007-7-38
110. Gaio, V., Nunes, B., Fernandes, A., Mendonça, F., Horta Correia, F., Beleza, A., et al. (2014). Genetic variation at the CYP2C19 gene associated with metabolic syndrome susceptibility in a South Portuguese population: results from the pilot study of the European Health Examination Survey in Portugal. Diabetol. Metab. Syndr. 6, 23. doi: 10.1186/1758-5996-6-23
111. Gao, Y., Lin, Y., Sun, K., Wang, Y., Chen, J., Wang, H., et al. (2014). Orthostatic blood pressure dysregulation and polymorphisms of beta-adrenergic receptor genes in hypertensive patients. J. Clin. Hypertens. (Greenwich) 16, 207-213. doi: 10.1111/jch.12272
112. Garfield, A. S., Li, C., Madara, J. C., Shah, B. P., Webber, E., Steger, J. S., et al. (2015). A neural basis for melanocortin-4 receptor-regulated appetite. Nat. Neurosci. 18, 863-871. doi: 10.1038/nn.4011
113. Ginsberg, H. N., and Stalenhoef, A. F. (2003). The metabolic syndrome: targeting dyslipidaemia to reduce coronary risk. J. Cardiovasc. Risk 10, 121-128. doi: 10.1177/174182670301000207
114. Girman, C. J., Rhodes, T., Mercuri, M., Pyörälä, K., Kjekshus, J., Pedersen, T. R., et al. (2004). The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am. J. Cardiol. 93, 136-141. doi: 10.1016/j.amjcard.2003.09.028
115. Gøtzsche, C. R., Nikitidou, L., Sørensen, A. T., Olesen, M. V., Sørensen, G., Christiansen, S. H. O., et al. (2012). Combined gene overexpression of neuropeptide Y and its receptor Y5 in the hippocampus suppresses seizures. Neurobiol. Dis. 45, 288-296. doi: 10.1016/j.nbd.2011.08.012
116. Grassi, G., Cattaneo, B. M., Seravalle, G., Lanfranchi, A., and Mancia, G. (1998). Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension 31, 68-72. doi: 10.1161/01.HYP.31.1.68
117. Grassi, G., Dell'Oro, R., Quarti-Trevano, F., Scopelliti, F., Seravalle, G., Paleari, F., et al. (2005). Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia 48, 1359-1365. doi: 10.1007/s00125-005-1798-z
118. Grassi, G., Quarti-Trevano, F., Seravalle, G., and Dell'Oro, R. (2007). Cardiovascular risk and adrenergic overdrive in the metabolic syndrome. Nutr. Metab. Cardiovasc. Dis. 17, 473-481. doi: 10.1016/j.numecd.2007.01.004
119. Green, B. B., Armstrong, D. A., Lesseur, C., Paquette, A. G., Guerin, D. J., Kwan, L. E., et al. (2015). The role of placental 11-beta hydroxysteroid dehydrogenase type 1 and type 2 methylation on gene expression and infant birth weight. Biol. Reprod. 92:149. doi: 10.1095/biolreprod.115.128066
120. Green, E., Fairchild, J. K., Kinoshita, L. M., Noda, A., and Yesavage, J. (2015). Effects of posttraumatic stress disorder and metabolic syndrome on cognitive aging in veterans. Gerontologist 56, 72-81. doi: 10.1093/geront/gnv040
121. Greenfield, J. R., Miller, J. W., Keogh, J. M., Henning, E., Satterwhite, J. H., Cameron, G. S., et al. (2009). Modulation of blood pressure by central melanocortinergic pathways. N. Engl. J. Med. 360, 44-52. doi: 10.1056/NEJMoa0803085
122. Grone, B. P., and Maruska, K. P. (2015). A second corticotropin-releasing hormone gene (CRH2) is conserved across vertebrate classes and expressed in the hindbrain of a basal neopterygian fish, the spotted gar (Lepisosteus oculatus). J. Comp. Neurol. 523, 1125-1143. doi: 10.1002/cne.23729
123. Grundy, S. M. (2015). Adipose tissue and metabolic syndrome: too much, too little or neither. Eur. J. Clin. Invest. 45, 1209-1217. doi: 10.1111/eci.12519
124. Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., et al. (2005b). Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: executive summary. Crit. Pathw. Cardiol. 4, 198-203. doi: 10.1097/00132577-200512000-00018
125. Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., et al. (2005a). Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112, 2735-2752. doi: 10.1161/CIRCULATIONAHA.105.169404
126. Gu, S. J., Guo, Z. R., Zhou, Z. Y., Hu, X. S., Wu, M., and Zhang, N. (2014). Peroxisome proliferatoractivated receptor gamma polymorphisms as risk factors for dyslipidemia. Mol. Med. Rep. 10, 2759-2763. doi: 10.3892/mmr.2014.2553
127. Guardiola, M., Oliva, I., Guillaumet, A., Martín-Trujillo, A., Rosales, R., Vallvé, J. C., et al. (2014). Tissue-specific DNA methylation profiles regulate liver-specific expression of the APOA1/C3/A4/A5 cluster and can be manipulated with demethylating agents on intestinal cells. Atherosclerosis 237, 528-535. doi: 10.1016/j.atherosclerosis.2014.10.029
128. Guarente, L. (2006). Sirtuins as potential targets for metabolic syndrome. Nature 444, 868-874. doi: 10.1038/nature05486
129. Guay, S. P., Brisson, D., Lamarche, B., Biron, S., Lescelleur, O., Biertho, L., et al. (2014). ADRB3 gene promoter DNA methylation in blood and visceral adipose tissue is associated with metabolic disturbances in men. Epigenomics 6, 33-43. doi: 10.2217/epi.13.82
130. Gyllenhammer, L. E., Alderete, T. L., Mahurka, S., Allayee, H., and Goran, M. I. (2014). Adipose tissue 11betaHSD1 gene expression, betacell function and ectopic fat in obese African Americans versus Hispanics. Obesity (Silver Spring) 22, 14-18. doi: 10.1002/oby.20571
131. Hall, E., Volkov, P., Dayeh, T., Bacos, K., Rönn, T., Nitert, M. D., et al. (2014). Effects of palmitate on genome-wide mRNA expression and DNA methylation patterns in human pancreatic islets. BMC Med. 12:103. doi: 10.1186/1741-7015-12-103
132. Hall, J. E., da Silva, A. A., do Carmo, J. M., Dubinion, J., Hamza, S., Munusamy, S., et al. (2010). Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins. J. Biol. Chem. 285, 17271-17276. doi: 10.1074/jbc. R110.113175
133. Haller, H., and Hanefeld, M. (1975). "Synoptische Betrachtung metabolischer Risikofaktoren," in Lipidstoffwechselstörungen, eds H. Haller, M. Hanefeld, and W. Jaross (Jena: Gustav Fischer Verlag), 254-64.
134. Haller, H., and Leonhardt, W. (1981). Das metabolische Syndrom. Dtsch Gesundheitwes 36, 545-551.
135. Han, R., Kitlinska, J. B., Munday, W. R., Gallicano, G. I., and Zukowska, Z. (2012). Stress hormone epinephrine enhances adipogenesis in murine embryonic stem cells by up-regulating the neuropeptide Y system. PLoS ONE 7:e36609. doi: 10.1371/journal.pone.0036609
136. Hart, E. C., Wallin, B. G., Barnes, J. N., Joyner, M. J., and Charkoudian, N. (2014). Sympathetic nerve activity and peripheral vasodilator capacity in young and older men. Am. J. Physiol. Heart Circ. Physiol. 306, H904-H909. doi: 10.1152/ajpheart.00181.2013
137. He, D., Fu, M., Miao, S., Hotta, K., Chandak, G. R., and Xi, B. (2014). FTO gene variant and risk of hypertension: a meta-analysis of 57,464 hypertensive cases and 41,256 controls. Metab. Clin. Exp. 63, 633-639. doi: 10.1016/j.metabol.2014.02.008
138. He, F. J., Li, J., and Macgregor, G. A. (2013). Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ 346:f1325. doi: 10.1136/bmj.f1325
139. Herzer, S., Silahtaroglu, A., and Meister, B. (2012). Locked nucleic acid-based in situ hybridisation reveals miR-7a as a hypothalamus-enriched microRNA with a distinct expression pattern. J. Neuroendocrinol. 24, 1492-1504. doi: 10.1111/j.1365-2826.2012.02358.x
140. Hintzpeter, J., Stapelfeld, C., Loerz, C., Martin, H. J., and Maser, E. (2014). Green tea and one of its constituents, epigallocatechine-3-gallate, are potent inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1. PLoS ONE 9:e84468. doi: 10.1371/journal.pone.0084468
141. Hjemdahl, P. (2002). Stress and the metabolic syndrome: an interesting but enigmatic association. Circulation 106, 2634-2636. doi: 10.1161/01.CIR.0000041502.43564.79
142. Hotamisligil, G. S. (2010a). Endoplasmic reticulum stress and atherosclerosis. Nat. Med. 16, 396-399. doi: 10.1038/nm0410-396
143. Hotamisligil, G. S. (2010b). Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140, 900-917. doi: 10.1016/j.cell.2010.02.034
144. Houde, A.-A., Légaré, C., Hould, F.-S., Lebel, S., Marceau, P., Tchernof, A., et al. (2014). Cross-tissue comparisons of leptin and adiponectin: DNA methylation profiles. Adipocyte 3, 132-140. doi: 10.4161/adip.28308
145. Huang, W., Sun, Y., and Sun, J. (2011). Combined effects of FTO rs9939609 and MC4R rs17782313 on obesity and BMI in Chinese Han populations. Endocrine 39, 69-74. doi: 10.1007/s12020-010-9413-6
146. Huggett, R. J., Burns, J., Mackintosh, A. F., and Mary, D. A. (2004). Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension. Hypertension 44, 847-852. doi: 10.1161/01.HYP.0000147893.08533.d8
147. Hummasti, S., and Hotamisligil, G. S. (2010). Endoplasmic reticulum stress and inflammation in obesity and diabetes. Circ. Res. 107, 579-591. doi: 10.1161/CIRCRESAHA.110.225698
148. Huvenne, H., Le Beyec, J., Pépin, D., Alili, R., Kherchiche, P. P., Jeannic, E., et al. (2015). Seven novel deleterious LEPR mutations found in early-onset obesity: a DeltaExon6-8 shared by subjects from Reunion Island, France, suggests a founder effect. J. Clin. Endocrinol. Metab. 100, E757-E766. doi: 10.1210/jc.2015-1036
149. Iannitti, T., Graham, A., and Dolan, S. (2015). Adiponectin-mediated analgesia and anti-inflammatory effects in rat. PLoS ONE 10:e0136819. doi: 10.1371/journal.pone.0136819
150. Inder, W. J., Obeyesekere, V. R., Jang, C., and Saffery, R. (2012). Evidence for transcript-specific epigenetic regulation of glucocorticoid-stimulated skeletal muscle 11beta-hydroxysteroid dehydrogenase-1 activity in type 2 diabetes. Clin. Epigenetics 4:24. doi: 10.1186/1868-7083-4-24
151. Iwen, K. A., Senyaman, O., Schwartz, A., Drenckhan, M., Meier, B., Hadaschik, D., et al. (2008). Melanocortin crosstalk with adipose functions: ACTH directly induces insulin resistance, promotes a pro-inflammatory adipokine profile and stimulates UCP-1 in adipocytes. J. Endocrinol. 196, 465-472. doi: 10.1677/JOE-07-0299
152. Jeon, J. P., Shim, S. M., Nam, H. Y., Ryu, G. M., Hong, E. J., Kim, H. L., et al. (2010). Copy number variation at leptin receptor gene locus associated with metabolic traits and the risk of type 2 diabetes mellitus. BMC Genomics 11:426. doi: 10.1186/1471-2164-11-426
153. Jimenez-Gomez, Y., Mattison, J. A., Pearson, K. J., Martin-Montalvo, A., Palacios, H. H., Sossong, A. M., et al. (2013). Resveratrol improves adipose insulin signaling and reduces the inflammatory response in adipose tissue of rhesus monkeys on high-fat, high-sugar diet. Cell Metab. 18, 533-545. doi: 10.1016/j.cmet.2013.09.004
154. Jin, Z., Pu, L., Sun, L., Chen, W., Nan, N., Li, H., et al. (2014). Identification of susceptibility variants in ADIPOR1 gene associated with type 2 diabetes, coronary artery disease and the comorbidity of type 2 diabetes and coronary artery disease. PLoS ONE 9:e100339. doi: 10.1371/journal.pone.0100339
155. Joslin, E. P. (1921). The prevention of diabetes mellitus. JAMA 76, 79-84. doi: 10.1001/jama.1921.02630020001001
156. Julius, S., Valentini, M., and Palatini, P. (2000). Overweight and hypertension: a 2-way street? Hypertension 35, 807-813. doi: 10.1161/01.HYP.35.3.807
157. Kalnina, I., Kapa, I., Pirags, V., Ignatovica, V., Schiöth, H. B., and Klovins, J. (2009). Association between a rare SNP in the second intron of human Agouti related protein gene and increased BMI. BMC Med. Genet. 10:63. doi: 10.1186/1471-2350-10-63
158. Kameswaran, V., Bramswig, N. C., McKenna, L. B., Penn, M., Schug, J., Hand, N. J., et al. (2014). Epigenetic regulation of the DLK1-MEG3 microRNA cluster in human type 2 diabetic islets. Cell Metab. 19, 135-145. doi: 10.1016/j.cmet.2013.11.016
159. Kang, K. T. (2014). Endothelium-derived relaxing factors of small resistance arteries in hypertension. Toxicol. Res. 30, 141-148. doi: 10.5487/TR.2014.30.3.141
160. Karbiener, M., Fischer, C., Nowitsch, S., Opriessnig, P., Papak, C., Ailhaud, G., et al. (2009). microRNA miR-27b impairs human adipocyte differentiation and targets PPARgamma. Biochem. Biophys. Res. Commun. 390, 247-251. doi: 10.1016/j.bbrc.2009.09.098
161. Katome, T., Namekata, K., Mitamura, Y., Semba, K., Egawa, M., Naito, T., et al. (2015). Expression of intraocular peroxisome proliferator-activated receptor gamma in patients with proliferative diabetic retinopathy. J. Diabetes Complicat. 29, 275-281. doi: 10.1016/j.jdiacomp.2014.10.010
162. Katsuura-Kamano, S., Uemura, H., Arisawa, K., Yamaguchi, M., Hamajima, N., Wakai, K., et al. (2014). A polymorphism near MC4R gene (rs17782313) is associated with serum triglyceride levels in the general Japanese population: the J-MICC Study. Endocrine 47, 81-89. doi: 10.1007/s12020-014-0306-y
163. Kaufman, L. N., Young, J. B., and Landsberg, L. (1986). Effect of protein on sympathetic nervous system activity in the rat. Evidence for nutrient-specific responses. J. Clin. Invest. 77, 551-558. doi: 10.1172/JCI112336
164. Khoroshinina, L. P., Tur'eva, L. V., Glotov, O. S., Poliakova, I. V., and Baranov, V. S. (2014). [Frequency of some diseases and conditions in geriatric patients with coronary heart disease and various genotypes of transcription factor 7-like 2 protein]. Adv. Gerontol. 27, 704-709.
165. Kilgour, A. H., Semple, S., Marshall, I., Andrews, P., Andrew, R., and Walker, B. R. (2015). 11beta-hydroxysteroid dehydrogenase activity in the brain does not contribute to systemic interconversion of cortisol and cortisone in healthy men. J. Clin. Endocrinol. Metab. 100, 483-489. doi: 10.1210/jc.2014-3277
166. Kilic, I. D., Dodurga, Y., Uludag, B., Alihanoglu, Y. I., Yildiz, B. S., Enli, Y., et al. (2015). MicroRNA -143 and -223 in obesity. Gene 560, 140-142. doi: 10.1016/j.gene.2015.01.048
167. Kim, M. K., Tanaka, K., Kim, M. J., Matsuo, T., and Ajisaka, R. (2009). Exercise training-induced changes in heart rate recovery in obese men with metabolic syndrome. Metab. Syndr. Relat. Disord. 7, 469-476. doi: 10.1089/met.2008.0086
168. Kim, S. Y., Kim, A. Y., Lee, H. W., Son, Y. H., Lee, G. Y., Lee, J. W., et al. (2010). miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARgamma expression. Biochem. Biophys. Res. Commun. 392, 323-328. doi: 10.1016/j.bbrc.2010.01.012
169. Kisiswa, L., Osório, C., Erice, C., Vizard, T., Wyatt, S., and Davies, A. M. (2013). TNFalpha reverse signaling promotes sympathetic axon growth and target innervation. Nat. Neurosci. 16, 865-873. doi: 10.1038/nn.3430
170. Kooijman, S., Boon, M. R., Parlevliet, E. T., Geerling, J. J., van de Pol, V., Romijn, J. A., et al. (2014). Inhibition of the central melanocortin system decreases brown adipose tissue activity. J. Lipid Res. 55, 2022-2032. doi: 10.1194/jlr. M045989
171. Kopin, I. J., Lake, R. C., and Ziegler, M. (1978). Plasma levels of norepinephrine. Ann. Intern. Med. 88, 671-680. doi: 10.7326/0003-4819-88-5-671
172. Koska, J., de Courten, B., Wake, D. J., Nair, S., Walker, B. R., Bunt, J. C., et al. (2006). 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue and prospective changes in body weight and insulin resistance. Obesity (Silver Spring) 14, 1515-1522. doi: 10.1038/oby.2006.175
173. Krashes, M. J., Lowell, B. B., and Garfield, A. S. (2016). Melanocortin-4 receptor-regulated energy homeostasis. Nat. Neurosci. 19, 206-219. doi: 10.1038/nn.4202
174. Kuehl, L. K., Hinkelmann, K., Muhtz, C., Dettenborn, L., Wingenfeld, K., Spitzer, C., et al. (2015). Hair cortisol and cortisol awakening response are associated with criteria of the metabolic syndrome in opposite directions. Psychoneuroendocrinology 51, 365-370. doi: 10.1016/j.psyneuen.2014.09.012
175. Kuehnen, P., Mischke, M., Wiegand, S., Sers, C., Horsthemke, B., Lau, S., et al. (2012). An Alu element-associated hypermethylation variant of the POMC gene is associated with childhood obesity. PLoS Genet. 8:e1002543. doi: 10.1371/journal.pgen.1002543
176. Kuo, L. E., Kitlinska, J. B., Tilan, J. U., Li, L., Baker, S. B., Johnson, M. D., et al. (2007). Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat. Med. 13, 803-811. doi: 10.1038/nm1611
177. Kurylowicz, A., Jonas, M., Lisik, W., Jonas, M., Wicik, Z. A., Wierzbicki, Z., et al. (2015). Obesity is associated with a decrease in expression but not with the hypermethylation of thermogenesis-related genes in adipose tissues. J. Transl. Med. 13, 31. doi: 10.1186/s12967-015-0395-2
178. Kylin, E. (1921). Hypertonie u. Zuckerkrankheit: Beitrag zur Symptomatologie des Altersdiabetes. Zentralbl Inn Med 42, 873-877.
179. Kylin, E. (1923). Studien über das Hypertonie-, Hyperglycämie-, und Hyperurikämiesyndrom. Zentralbl Inn Med 44, 105-125.
180. Lambert, E., Dawood, T., Straznicky, N., Sari, C., Schlaich, M., Esler, M., et al. (2010). Association between the sympathetic firing pattern and anxiety level in patients with the metabolic syndrome and elevated blood pressure. J. Hypertens. 28, 543-550. doi: 10.1097/HJH.0b013e3283350ea4
181. Lamers, F., Vogelzangs, N., Merikangas, K. R., de Jonge, P., Beekman, A. T., and Penninx, B. W. (2013). Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression. Mol. Psychiatry 18, 692-699. doi: 10.1038/mp.2012.144
182. Landsberg, L. (1986). Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. Q. J. Med. 61, 1081-1090.
183. Landsberg, L., and Young, J. B. (1986). Caloric intake and sympathetic nervous system activity. Implications for blood pressure regulation and thermogenesis. J. Clin. Hypertens. 2, 166-171.
184. Laurila, M., Santaniemi, M., Kesäniemi, Y. A., and Ukkola, O. (2014). High plasma ghrelin protects from coronary heart disease and Leu72Leu polymorphism of ghrelin gene from cancer in healthy adults during the 19 years follow-up study. Peptides 61, 122-129. doi: 10.1016/j.peptides.2014.09.012
185. Lee, J. H., Gao, Z., and Ye, J. (2013). Regulation of 11beta-HSD1 expression during adipose tissue expansion by hypoxia through different activities of NF-kappaB and HIF-1alpha. Am. J. Physiol. Endocrinol. Metab. 304, E1035-E1041. doi: 10.1152/ajpendo.00029.2013
186. Lefterova, M. I., Haakonsson, A. K., Lazar, M. A., and Mandrup, S. (2014). PPARgamma and the global map of adipogenesis and beyond. Trends Endocrinol. Metab. 25, 293-302. doi: 10.1016/j.tem.2014.04.001
187. Lehrke, M., Broedl, U. C., Biller-Friedmann, I. M., Vogeser, M., Henschel, V., Nassau, K., et al. (2008). Serum concentrations of cortisol, interleukin 6, leptin and adiponectin predict stress induced insulin resistance in acute inflammatory reactions. Crit. Care 12, R157. doi: 10.1186/cc7152
188. Lemche, A. V., Chaban, O. S., and Lemche, E. (2016). Trait anxiety but not state anxiety level associates with biomarkers for hypertension in the metabolic syndrome. Psychophysiology. doi: 10.1111/psyp.12623. [Epub ahead of print].
189. Lemche, E., Giampietro, V. P., Surguladze, S. A., Amaro, E. J., Andrew, C. M., Williams, S. C., et al. (2006). Human attachment security is mediated by the amygdala: evidence from combined fMRI and psychophysiological measures. Hum. Brain Mapp. 27, 623-635. doi: 10.1002/hbm.20206
190. Lewis, J. G., Borowski, K. K., Shand, B. I., George, P. M., and Scott, R. S. (2010). Plasma sex hormone-binding globulin, corticosteroid-binding globulin, cortisol, and free cortisol levels in outpatients attending a lipid disorders clinic: a cross-sectional study of 1137 subjects. Horm. Metab. Res. 42, 274-279. doi: 10.1055/s-0029-1243260
191. Li, J., Zhou, C., Li, J., Su, Z., Sang, H., Jia, E., et al. (2015). Global correlation analysis for microRNA and gene expression profiles in human obesity. Pathol. Res. Pract. 211, 361-368. doi: 10.1016/j.prp.2014.11.014
192. Li, P., Tiwari, H. K., Lin, W. Y., Allison, D. B., Chung, W. K., Leibel, R. L., et al. (2014). Genetic association analysis of 30 genes related to obesity in a European American population. Int. J. Obes. (Lond.) 38, 724-729. doi: 10.1038/ijo.2013.140
193. Liguori, R., Labruna, G., Alfieri, A., Martone, D., Farinaro, E., Contaldo, F., et al. (2014). The FTO gene polymorphism (rs9939609) is associated with metabolic syndrome in morbidly obese subjects from southern Italy. Mol. Cell. Probes 28, 195-199. doi: 10.1016/j.mcp.2014.03.004
194. Lin, X., Qi, Q., Zheng, Y., Huang, T., Lathrop, M., Zelenika, D., et al. (2015). Neuropeptide Y genotype, central obesity, and abdominal fat distribution: the POUNDS LOST trial. Am. J. Clin. Nutr. 102, 514-519. doi: 10.3945/ajcn.115.107276
195. Lindberg, S., Jensen, J. S., Bjerre, M., Pedersen, S. H., Frystyk, J., Flyvbjerg, A., et al. (2015). Adiponectin, type 2 diabetes and cardiovascular risk. Eur. J. Prev. Cardiol. 22, 276-283. doi: 10.1177/2047487313514894
196. Lofgren, I., Zern, T., Herron, K., West, K., Sharman, M. J., Volek, J. S., et al. (2005). Weight loss associated with reduced intake of carbohydrate reduces the atherogenicity of LDL in premenopausal women. Metab. Clin. Exp. 54, 1133-1141. doi: 10.1016/j.metabol.2005.03.019
197. Loos, R. J., Lindgren, C. M., Li, S., Wheeler, E., Zhao, J. H., Prokopenko, I., et al. (2008). Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat. Genet. 40, 768-775. doi: 10.1038/ng.140
198. Lu, X., Wang, L., Lin, X., Huang, J., Charles Gu, C., He, M., et al. (2015). Genome-wide association study in Chinese identifies novel loci for blood pressure and hypertension. Hum. Mol. Genet. 24, 865-874. doi: 10.1093/hmg/ddu478
199. Lyssenko, V., Almgren, P., Anevski, D., Orho-Melander, M., Sjögren, M., Saloranta, C., et al. (2005). Genetic prediction of future type 2 diabetes. PLoS Med. 2:e345. doi: 10.1371/journal.pmed.0020345
200. Mahmood, S., Smiraglia, D. J., Srinivasan, M., and Patel, M. S. (2013). Epigenetic changes in hypothalamic appetite regulatory genes may underlie the developmental programming for obesity in rat neonates subjected to a high-carbohydrate dietary modification. J. Dev. Orig. Health Dis. 4, 479-490. doi: 10.1017/S2040174413000238
201. Mancia, G., Daffonchio, A., Di Rienzo, M., Ferrari, A. U., and Grassi, G. (1998). Methods to quantify sympathetic cardiovascular influences. Eur. Heart J. 19(Suppl. F), F7-F13.
202. Maranon, G. (1922). über Hypertonie und Zuckerkrankheit. Zentralblatt Innere Medizin 43, 169-176.
203. Mark, A. L. (2013). Selective leptin resistance revisited. Am. J. Physiol. Regul. Integr. Comp. Physiol. 305, R566-R581. doi: 10.1152/ajpregu.00180.2013
204. Martín-Blanco, A., Ferrer, M., Soler, J., Salazar, J., Vega, D., Andión, O., et al. (2014). Association between methylation of the glucocorticoid receptor gene, childhood maltreatment, and clinical severity in borderline personality disorder. J. Psychiatr. Res. 57, 34-40. doi: 10.1016/j.jpsychires.2014.06.011
205. Masuo, K., Mikami, H., Ogihara, T., and Tuck, M. L. (1997). Sympathetic nerve hyperactivity precedes hyperinsulinemia and blood pressure elevation in a young, nonobese Japanese population. Am. J. Hypertens. 10, 77-83. doi: 10.1016/S0895-7061(96)00303-2
206. Masuo, K., Straznicky, N. E., Lambert, G. W., Katsuya, T., Sugimoto, K., Rakugi, H., et al. (2008). Leptin-receptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic nerve activation in a Caucasian male population. Hypertens. Res. 31, 1093-1100. doi: 10.1291/hypres.31.1093
207. McGregor, B. A., Murphy, K. M., Albano, D. L., and Ceballos, R. M. (2015). Stress, cortisol, and B-lymphocytes: a novel approach to understanding academic stress and immune function. Stress. doi: 10.3109/10253890.2015.1127913. [Epub ahead of print].
208. McGregor, R. A., and Choi, M. S. (2011). microRNAs in the regulation of adipogenesis and obesity. Curr. Mol. Med. 11, 304-316. doi: 10.2174/156652411795677990
209. Melka, M. G., Abrahamowicz, M., Leonard, G. T., Perron, M., Richer, L., Veillette, S., et al. (2013). Clustering of the metabolic syndrome components in adolescence: role of visceral fat. PLoS ONE 8:e82368. doi: 10.1371/journal.pone.0082368
210. Mells, J. E., Fu, P. P., Kumar, P., Smith, T., Karpen, S. J., and Anania, F. A. (2015). Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis. J. Nutr. Biochem. 26, 285-292. doi: 10.1016/j.jnutbio.2014.11.002
211. Millington, G. W. (2007). The role of proopiomelanocortin (POMC) neurones in feeding behaviour. Nutr. Metab. (Lond.) 4:18. doi: 10.1186/1743-7075-4-18
212. Mlyniec, K., Singewald, N., Holst, B., and Nowak, G. (2015). GPR39 Zn(2+)-sensing receptor: a new target in antidepressant development? J. Affect. Disord. 174, 89-100. doi: 10.1016/j.jad.2014.11.033
213. Morales, E., Groom, A., Lawlor, D. A., and Relton, C. L. (2014). DNA methylation signatures in cord blood associated with maternal gestational weight gain: results from the ALSPAC cohort. BMC Res. Notes 7:278. doi: 10.1186/1756-0500-7-278
214. Morash, B., Li, A., Murphy, P. R., Wilkinson, M., and Ur, E. (1999). Leptin gene expression in the brain and pituitary gland. Endocrinology 140, 5995-5998. doi: 10.1210/endo.140.12.7288
215. Moreira, M. C. S., Pinto, I. S., Mourão, A. A., Fajemiroye, J. O., Colombari, E., Reis, Â. A. S., et al. (2015). Does the sympathetic nervous system contribute to the pathophysiology of metabolic syndrome? Front. Physiol. 6:234. doi: 10.3389/fphys.2015.00234
216. Muller, Y. L., Thearle, M. S., Piaggi, P., Hanson, R. L., Hoffman, D., Gene, B., et al. (2014). Common genetic variation in and near the melanocortin 4 receptor gene (MC4R) is associated with body mass index in American Indian adults and children. Hum. Genet. 133, 1431-1441. doi: 10.1007/s00439-014-1477-6
217. Mune, T., Suwa, T., Morita, H., Isomura, Y., Takada, N., Yamamoto, Y., et al. (2013). Longer HSD11B2 CA-repeat in impaired glucose tolerance and type 2 diabetes. Endocr. J. 60, 671-678. doi: 10.1507/endocrj. EJ12-0108
218. Muramatsu-Kato, K., Itoh, H., Kobayashi-Kohmura, Y., Murakami, H., Uchida, T., Suzuki, K., et al. (2014). Comparison between placental gene expression of 11beta-hydroxysteroid dehydrogenases and infantile growth at 10 months of age. J. Obstet. Gynaecol. Res. 40, 465-472. doi: 10.1111/jog.12200
219. Napoli, E., Tassone, F., Wong, S., Angkustsiri, K., Simon, T. J., Song, G., et al. (2015). Mitochondrial citrate transporter-dependent metabolic signature in the 22q11.2 deletion syndrome. J. Biol. Chem. 290, 23240-23253. doi: 10.1074/jbc. M115.672360
220. Nelson, R. A., and Bremer, A. A. (2010). Insulin resistance and metabolic syndrome in the pediatric population. Metab. Syndr. Relat. Disord. 8, 1-14. doi: 10.1089/met.2009.0068
221. Nilsson, E., Jansson, P. A., Perfilyev, A., Volkov, P., Pedersen, M., Svensson, M. K., et al. (2014). Altered DNA methylation and differential expression of genes influencing metabolism and inflammation in adipose tissue from subjects with type 2 diabetes. Diabetes 63, 2962-2976. doi: 10.2337/db13-1459
222. Nilsson, S. K., Christensen, S., Raarup, M. K., Ryan, R. O., Nielsen, M. S., and Olivecrona, G. (2008). Endocytosis of apolipoprotein A-V by members of the low density lipoprotein receptor and the VPS10p domain receptor families. J. Biol. Chem. 283, 25920-25927. doi: 10.1074/jbc. M802721200
223. Nitert, M. D., Dayeh, T., Volkov, P., Elgzyri, T., Hall, E., Nilsson, E., et al. (2012). Impact of an exercise intervention on DNA methylation in skeletal muscle from first-degree relatives of patients with type 2 diabetes. Diabetes 61, 3322-3332. doi: 10.2337/db11-1653
224. Nussey, S. S., Soo, S. C., Gibson, S., Gout, I., White, A., Bain, M., et al. (1993). Isolated congenital ACTH deficiency: a cleavage enzyme defect? Clin. Endocrinol. (Oxf.) 39, 381-385.
225. Oh, S. W., Han, K. H., Han, S. Y., Koo, H. S., Kim, S., and Chin, H. J. (2015). Association of sodium excretion with metabolic syndrome, insulin resistance, and body fat. Medicine (Baltimore) 94:e1650. doi: 10.1097/MD.0000000000001650
226. Oka, Y., Ye, M., and Zuker, C. S. (2015). Thirst driving and suppressing signals encoded by distinct neural populations in the brain. Nature 520, 349-352. doi: 10.1038/nature14108
227. Oler, J. A., Fox, A. S., Shelton, S. E., Rogers, J., Dyer, T. D., Davidson, R. J., et al. (2010). Amygdalar and hippocampal substrates of anxious temperament differ in their heritability. Nature 466, 864-868. doi: 10.1038/nature09282
228. Olesen, M. V., Christiansen, S. H., Gøtzsche, C. R., Holst, B., Kokaia, M., and Woldbye, D. P. D. (2012a). Y5 neuropeptide Y receptor overexpression in mice neither affects anxiety- and depression-like behaviours nor seizures but confers moderate hyperactivity. Neuropeptides 46, 71-79. doi: 10.1016/j.npep.2012.01.002
229. Olesen, M. V., Christiansen, S. H., Gøtzsche, C. R., Nikitidou, L., Kokaia, M., and Woldbye, D. P. D. (2012b). Neuropeptide Y Y1 receptor hippocampal overexpression via viral vectors is associated with modest anxiolytic-like and proconvulsant effects in mice. J. Neurosci. Res. 90, 498-507. doi: 10.1002/jnr.22770
230. Olofsson, P. S., Katz, D. A., Rosas-Ballina, M., Levine, Y. A., Ochani, M., Valdés-Ferrer, S. I., et al. (2012). alpha7 nicotinic acetylcholine receptor (alpha7nAChR) expression in bone marrow-derived non-T cells is required for the inflammatory reflex. Mol. Med. 18, 539-543. doi: 10.2119/molmed.2011.00405
231. Osorio, J. S., Ji, P., Drackley, J. K., Luchini, D., and Loor, J. J. (2014). Smartamine, M., and MetaSmart supplementation during the peripartal period alter hepatic expression of gene networks in 1-carbon metabolism, inflammation, oxidative stress, and the growth hormone-insulin-like growth factor 1 axis pathways. J. Dairy Sci. 97, 7451-7464. doi: 10.3168/jds.2014-8680
232. Oswal, A., and Yeo, G. (2010). Leptin and the control of body weight: a review of its diverse central targets, signaling mechanisms, and role in the pathogenesis of obesity. Obesity (Silver Spring) 18, 221-229. doi: 10.1038/oby.2009.228
233. Ouhaibi-Djellouli, H., Mediene-Benchekor, S., Lardjam-Hetraf, S. A., Hamani-Medjaoui, I., Meroufel, D. N., Boulenouar, H., et al. (2014). The TCF7L2 rs7903146 polymorphism, dietary intakes and type 2 diabetes risk in an Algerian population. BMC Genet. 15:134. doi: 10.1186/s12863-014-0134-3
234. Pabalan, N. A., Seim, I., Jarjanazi, H., and Chopin, L. K. (2014). Associations between ghrelin and ghrelin receptor polymorphisms and cancer in Caucasian populations: a meta-analysis. BMC Genet. 15:118. doi: 10.1186/s12863-014-0118-3
235. Palma-Gudiel, H., Córdova-Palomera, A., Leza, J. C., and Fañanás, L. (2015). Glucocorticoid receptor gene (NR3C1) methylation processes as mediators of early adversity in stress-related disorders causality: a critical review. Neurosci. Biobehav. Rev. 55, 520-535. doi: 10.1016/j.neubiorev.2015.05.016
236. Palmer, J. D., Soule, B. P., Simone, B. A., Zaorsky, N. G., Jin, L., and Simone, N. L. (2014). MicroRNA expression altered by diet: can food be medicinal? Ageing Res. Rev. 17, 16-24. doi: 10.1016/j.arr.2014.04.005
237. Parekh, P. J., Arusi, E., Vinik, A. I., and Johnson, D. A. (2014). The role and influence of gut microbiota in pathogenesis and management of obesity and metabolic syndrome. Front. Endocrinol. (Lausanne) 5:47. doi: 10.3389/fendo.2014.00047
238. Pavlov, V. A., and Tracey, K. J. (2012). The vagus nerve and the inflammatory reflex-linking immunity and metabolism. Nat. Rev. Endocrinol. 8, 743-754. doi: 10.1038/nrendo.2012.189
239. Peeke, P. M., and Chrousos, G. P. (1995). Hypercortisolism and obesity. Ann. N.Y. Acad. Sci. 771, 665-676. doi: 10.1111/j.1749-6632.1995.tb44719.x
240. Peng, Y., Xiang, H., Chen, C., Zheng, R., Chai, J., Peng, J., et al. (2013). MiR-224 impairs adipocyte early differentiation and regulates fatty acid metabolism. Int. J. Biochem. Cell Biol. 45, 1585-1593. doi: 10.1016/j.biocel.2013.04.029
241. Peng, Y., Yu, S., Li, H., Xiang, H., Peng, J., and Jiang, S. (2014). MicroRNAs: emerging roles in adipogenesis and obesity. Cell. Signal. 26, 1888-1896. doi: 10.1016/j.cellsig.2014.05.006
242. Pennacchio, L. A., Olivier, M., Hubacek, J. A., Cohen, J. C., Cox, D. R., Fruchart, J. C., et al. (2001). An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294, 169-173. doi: 10.1126/science.1064852
243. Perez-Tilve, D., Hofmann, S. M., Basford, J., Nogueiras, R., Pfluger, P. T., Patterson, J. T., et al. (2010). Melanocortin signaling in the CNS directly regulates circulating cholesterol. Nat. Neurosci. 13, 877-882. doi: 10.1038/nn.2569
244. Perry, C., Sattar, N., and Petrie, J. (2001). Adipose tissue: passive sump or active pump? Br. J. Diabetes Vasc. Dis. Res. 1, 110-114. doi: 10.1177/14746514010010020801
245. Pietrzak, R. H., Sumner, J. A., Aiello, A. E., Uddin, M., Neumeister, A., Guffanti, G., et al. (2015). Association of the rs2242446 polymorphism in the norepinephrine transporter gene SLC6A2 and anxious arousal symptoms of posttraumatic stress disorder. J. Clin. Psychiatry 76, e537-e538. doi: 10.4088/JCP.14l09346
246. Pinto, C. G., Marega, M., Carvalho, J. A., Carmona, F. G., Lopes, C. E., Ceschini, F. L., et al. (2015). Physical activity as a protective factor for development of non-alcoholic fatty liver in men. Einstein (Sao Paulo) 13, 34-40. doi: 10.1590/S1679-45082015AO2878
247. Plagemann, A., Harder, T., Brunn, M., Harder, A., Roepke, K., Wittrock-Staar, M., et al. (2009). Hypothalamic proopiomelanocortin promoter methylation becomes altered by early overfeeding: an epigenetic model of obesity and the metabolic syndrome. J. Physiol. 587(Pt 20), 4963-4976. doi: 10.1113/jphysiol.2009.176156
248. Proudfoot, N. J. (2011). Ending the message: poly(A) signals then and now. Genes Dev. 25, 1770-1782. doi: 10.1101/gad.17268411
249. Putku, M., Kals, M., Inno, R., Kasela, S., Org, E., Koích, V., et al. (2015). CDH13 promoter SNPs with pleiotropic effect on cardiometabolic parameters represent methylation QTLs. Hum. Genet. 134, 291-303. doi: 10.1007/s00439-014-1521-6
250. Rafiq, K., Fujisawa, Y., Sherajee, S. J., Rahman, A., Sufiun, A., Kobori, H., et al. (2015). Role of the renal sympathetic nerve in renal glucose metabolism during the development of type 2 diabetes in rats. Diabetologia 58, 2885-2898. doi: 10.1007/s00125-015-3771-9
251. Raucci, R., Rusolo, F., Sharma, A., Colonna, G., Castello, G., and Costantini, S. (2013). Functional and structural features of adipokine family. Cytokine 61, 1-14. doi: 10.1016/j.cyto.2012.08.036
252. Reaven, G. M. (1988). Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37, 1595-1607. doi: 10.2337/diab.37.12.1595
253. Remely, M., Aumueller, E., Jahn, D., Hippe, B., Brath, H., and Haslberger, A. G. (2014a). Microbiota and epigenetic regulation of inflammatory mediators in type 2 diabetes and obesity. Benef. Microbes 5, 33-43. doi: 10.3920/BM2013.006
254. Remely, M., Aumueller, E., Merold, C., Dworzak, S., Hippe, B., Zanner, J., et al. (2014b). Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity. Gene 537, 85-92. doi: 10.1016/j.gene.2013.11.081
255. Renaldi, O., Pramono, B., Sinorita, H., Purnomo, L. B., Asdie, R. H., and Asdie, A. H. (2009). Hypoadiponectinemia: a risk factor for metabolic syndrome. Acta Med. Indones. 41, 20-24.
256. Révész, D., Milaneschi, Y., Verhoeven, J. E., Lin, J., and Penninx, B. W. (2015). Longitudinal associations between metabolic syndrome components and telomere shortening. J. Clin. Endocrinol. Metab. 100, 3050-3059. doi: 10.1210/JC.2015-1995
257. Reyes, M., Quintanilla, C., Burrows, R., Blanco, E., Cifuentes, M., and Gahagan, S. (2015). Obesity is associated with acute inflammation in a sample of adolescents. Pediatr. Diabetes 16, 109-116. doi: 10.1111/pedi.12129
258. Reynolds, R. M., Labad, J., Strachan, M. W., Braun, A., Fowkes, F. G., Lee, A. J., et al. (2010). Elevated fasting plasma cortisol is associated with ischemic heart disease and its risk factors in people with type 2 diabetes: the Edinburgh type 2 diabetes study. J. Clin. Endocrinol. Metab. 95, 1602-1608. doi: 10.1210/jc.2009-2112
259. Rezaei, M., Andrieu, T., Neuenschwander, S., Bruggmann, R., Mordasini, D., Frey, F. J., et al. (2014). Regulation of 11beta-hydroxysteroid dehydrogenase type 2 by microRNA. Hypertension 64, 860-866. doi: 10.1161/HYPERTENSIONAHA.114.00002
260. Richard, D. (2015). Cognitive and autonomic determinants of energy homeostasis in obesity. Nat. Rev. Endocrinol. 11, 489-501. doi: 10.1038/nrendo.2015.103
261. Ridderstråle, M., and Groop, L. (2009). Genetic dissection of type 2 diabetes. Mol. Cell. Endocrinol. 297, 10-17. doi: 10.1016/j.mce.2008.10.002
262. Riestra, P., Gebreab, S. Y., Xu, R., Khan, R. J., Bidulescu, A., Correa, A., et al. (2015). Gender-specific associations between ADIPOQ gene polymorphisms and adiponectin levels and obesity in the Jackson Heart Study cohort. BMC Med. Genet. 16:65. doi: 10.1186/s12881-015-0214-x
263. Rivera, M., Cohen-Woods, S., Kapur, K., Breen, G., Ng, M. Y., Butler, A. W., et al. (2012). Depressive disorder moderates the effect of the FTO gene on body mass index. Mol. Psychiatry 17, 604-611. doi: 10.1038/mp.2011.45
264. Rivier, C., Brownstein, M., Spiess, J., Rivier, J., and Vale, W. (1982). In vivo corticotropin-releasing factor-induced secretion of adrenocorticotropin, beta-endorphin, and corticosterone. Endocrinology 110, 272-278. doi: 10.1210/endo-110-1-272
265. Rogers, J., Raveendran, M., Fawcett, G. L., Fox, A. S., Shelton, S. E., Oler, J. A., et al. (2013). CRHR1 genotypes, neural circuits and the diathesis for anxiety and depression. Mol. Psychiatry 18, 700-707. doi: 10.1038/mp.2012.152
266. Rogers, S. L., Hughes, B. A., Jones, C. A., Freedman, L., Smart, K., Taylor, N., et al. (2014). Diminished 11beta-hydroxysteroid dehydrogenase type 2 activity is associated with decreased weight and weight gain across the first year of life. J. Clin. Endocrinol. Metab. 99, E821-E831. doi: 10.1210/jc.2013-3254
267. Rolland, V., Clement, K., Dugail, I., Guy-Grand, B., Basdevant, A., Froeuel, P., et al. (1998). Leptin receptor gene in a large cohort of massively obese subjects: no indication of the fa/fa rat mutation. Detection of an intronic variant with no association with obesity. Obes. Res. 6, 122-127. doi: 10.1002/j.1550-8528.1998.tb00325.x
268. Rönn, T., Volkov, P., Gillberg, L., Kokosar, M., Perfilyev, A., Jacobsen, A. L., et al. (2015). Impact of age, BMI and HbA1c levels on the genome-wide DNA methylation and mRNA expression patterns in human adipose tissue and identification of epigenetic biomarkers in blood. Hum. Mol. Genet. 24, 3792-3813. doi: 10.1093/hmg/ddv124
269. Rosas-Ballina, M., Ochani, M., Parrish, W. R., Ochani, K., Harris, Y. T., Huston, J. M., et al. (2008). Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proc. Natl. Acad. Sci. U.S.A. 105, 11008-11013. doi: 10.1073/pnas.0803237105
270. Rosas-Ballina, M., Olofsson, P. S., Ochani, M., Valdés-Ferrer, S. I., Levine, Y. A., Reardon, C., et al. (2011). Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science 334, 98-101. doi: 10.1126/science.1209985
271. Rosenbaum, S., Stubbs, B., Ward, P. B., Steel, Z., Lederman, O., and Vancampfort, D. (2015). The prevalence and risk of metabolic syndrome and its components among people with posttraumatic stress disorder: a systematic review and meta-analysis. Metab. Clin. Exp. 64, 926-933. doi: 10.1016/j.metabol.2015.04.009
272. Rossi, J., Balthasar, N., Olson, D., Scott, M., Berglund, E., Lee, C. E., et al. (2011). Melanocortin-4 receptors expressed by cholinergic neurons regulate energy balance and glucose homeostasis. Cell Metab. 13, 195-204. doi: 10.1016/j.cmet.2011.01.010
273. Ruan, L. L., Xu, J., Wang, C. L., and Zou, C. C. (2014). Variants of 11beta-hydroxysteroid dehydrogenase (HSD11B) gene type 1 and 2 in Chinese obese adolescents. J. Endocrinol. Invest. 37, 565-573. doi: 10.1007/s40618-014-0075-8
274. Russo, G. T., Meigs, J. B., Cupples, L. A., Demissie, S., Otvos, J. D., Wilson, P. W., et al. (2001). Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study. Atherosclerosis 158, 173-181. doi: 10.1016/S0021-9150(01)00409-9
275. Sanders, P. W. (2009). Dietary salt intake, salt sensitivity, and cardiovascular health. Hypertension 53, 442-445. doi: 10.1161/HYPERTENSIONAHA.108.120303
276. Sapkota, S., Vergote, D., Westaway, D., Jhamandas, J., and Dixon, R. A. (2015). Synergistic associations of catechol-O-methyltransferase and brain-derived neurotrophic factor with executive function in aging are selective and modified by apolipoprotein E. Neurobiol. Aging 36, 249-256. doi: 10.1016/j.neurobiolaging.2014.06.020
277. Sattar, N., Gaw, A., Scherbakova, O., Ford, I., O'Reilly, D. S., Haffner, S. M., et al. (2003). Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108, 414-419. doi: 10.1161/01.CIR.0000080897.52664.94
278. Schneeberger, M., Altirriba, J., García, A., Esteban, Y., Castaño, C., García-Lavandeira, M., et al. (2012). Deletion of miRNA processing enzyme Dicer in POMC-expressing cells leads to pituitary dysfunction, neurodegeneration and development of obesity. Mol. Metab. 2, 74-85. doi: 10.1016/j.molmet.2012.10.001
279. Schommer, N. C., Hellhammer, D. H., and Kirschbaum, C. (2003). Dissociation between reactivity of the hypothalamus-pituitary-adrenal axis and the sympathetic-adrenal-medullary system to repeated psychosocial stress. Psychosom. Med. 65, 450-460. doi: 10.1097/01.PSY.0000035721.12441.17
280. Schwenk, R. W., Jonas, W., Ernst, S. B., Kammel, A., Jähnert, M., and Schürmann, A. (2013). Diet-dependent alterations of hepatic Scd1 expression are accompanied by differences in promoter methylation. Horm. Metab. Res. 45, 786-794. doi: 10.1055/s-0033-1348263
281. Seckl, J. R., and Walker, B. R. (2001). Minireview: 11beta-hydroxysteroid dehydrogenase type 1-a tissue-specific amplifier of glucocorticoid action. Endocrinology 142, 1371-1376. doi: 10.1210/endo.142.4.8114
282. Seres, J., Bornstein, S. R., Seres, P., Willenberg, H. S., Schulte, K. M., Scherbaum, W. A., et al. (2004). Corticotropin-releasing hormone system in human adipose tissue. J. Clin. Endocrinol. Metab. 89, 965-970. doi: 10.1210/jc.2003-031299
283. Singh, P., Sharma, P., Sahakyan, K. R., Davison, D. E., Sert-Kuniyoshi, F. H., Romero-Corral, A., et al. (2016). Differential effects of leptin on adiponectin expression with weight gain versus obesity. Int. J. Obes. (Lond.) 40, 266-274. doi: 10.1038/ijo.2015.181
284. Sitticharoon, C., Chatree, S., and Churintaraphan, M. (2013). Expressions of neuropeptide Y and Y1 receptor in subcutaneous and visceral fat tissues in normal weight and obese humans and their correlations with clinical parameters and peripheral metabolic factors. Regul. Pept. 185, 65-72. doi: 10.1016/j.regpep.2013.06.015
285. Sitticharoon, C., Nway, N. C., Chatree, S., Churintaraphan, M., Boonpuan, P., and Maikaew, P. (2014). Interactions between adiponectin, visfatin, and omentin in subcutaneous and visceral adipose tissues and serum, and correlations with clinical and peripheral metabolic factors. Peptides 62, 164-175. doi: 10.1016/j.peptides.2014.10.006
286. Song, G., Xu, G., Ji, C., Shi, C., Shen, Y., Chen, L., et al. (2014). The role of microRNA-26b in human adipocyte differentiation and proliferation. Gene 533, 481-487. doi: 10.1016/j.gene.2013.10.011
287. Song, J. Y., Wang, D., Ma, J., and Wang, H. J. (2015). [Mutation screening and function prediction of melanocortin-4 receptor gene in obese children]. Zhongguo Dang Dai Er Ke Za Zhi 17, 356-361.
288. Song, J., Kang, S. M., Kim, E., Kim, C. H., Song, H. T., and Lee, J. E. (2015). Adiponectin receptor-mediated signaling ameliorates cerebral cell damage and regulates the neurogenesis of neural stem cells at high glucose concentrations: an in vivo and in vitro study. Cell Death Dis. 6, e1844. doi: 10.1038/cddis.2015.220
289. Sousa, N. (2016). The dynamics of the stress neuromatrix. Mol. Psychiatry 21, 302-312. doi: 10.1038/mp.2015.196
290. Sözen, M. A., de Jonge, L. H., Greenway, F., Ravussin, E., Smith, S. R., and Argyropoulos, G. (2007). A rare mutation in AgRP, +79G>A, affects promoter activity. Eur. J. Clin. Nutr. 61, 809-812. doi: 10.1038/sj.ejcn.1602585
291. Stalder, T., Kirschbaum, C., Alexander, N., Bornstein, S. R., Gao, W., Miller, R., et al. (2013). Cortisol in hair and the metabolic syndrome. J. Clin. Endocrinol. Metab. 98, 2573-2580. doi: 10.1210/jc.2013-1056
292. Statsenko, M. E., Turkina, S. V., and Kosivtseva, M. A. (2013). [Additional advantages of mexicor used in combined therapy of coronary heat disease and diabetes mellitus of 2nd type]. Klin. Med. (Mosk.) 91, 59-64.
293. Stimson, R. H., and Walker, B. R. (2013). The role and regulation of 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome. Horm. Mol. Biol. Clin. Investig. 15, 37-48. doi: 10.1515/hmbci-2013-0015
294. Stout, S. A., Espel, E. V., Sandman, C. A., Glynn, L. M., and Davis, E. P. (2015). Fetal programming of children's obesity risk. Psychoneuroendocrinology 53, 29-39. doi: 10.1016/j.psyneuen.2014.12.009
295. Straznicky, N. E., Eikelis, N., Lambert, E. A., and Esler, M. D. (2008). Mediators of sympathetic activation in metabolic syndrome obesity. Curr. Hypertens. Rep. 10, 440-447. doi: 10.1007/s11906-008-0083-1
296. Straznicky, N. E., Lambert, G. W., Masuo, K., Dawood, T., Eikelis, N., Nestel, P. J., et al. (2009). Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome. Am. J. Clin. Nutr. 89, 27-36. doi: 10.3945/ajcn.2008.26299
297. Stuber, G. D., and Wise, R. A. (2016). Lateral hypothalamic circuits for feeding and reward. Nat. Neurosci. 19, 198-205. doi: 10.1038/nn.4220
298. Stumvoll, M., Goldstein, B. J., and van Haeften, T. W. (2005). Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365, 1333-1346. doi: 10.1016/S0140-6736(05)61032-X
299. Subbannayya, T., Balakrishnan, L., Sudarshan, G., Advani, J., Kumar, S., Mahmood, R., et al. (2013). An integrated map of corticotropin-releasing hormone signaling pathway. J. Cell Commun. Signal. 7, 295-300. doi: 10.1007/s12079-013-0197-3
300. Sun, S., Ji, Y., Kersten, S., and Qi, L. (2012). Mechanisms of inflammatory responses in obese adipose tissue. Annu. Rev. Nutr. 32, 261-286. doi: 10.1146/annurev-nutr-071811-150623
301. Sutton, G. M., Begriche, K., Kumar, K. G., Gimble, J. M., Perez-Tilve, D., Nogueiras, R., et al. (2010). Central nervous system melanocortin-3 receptors are required for synchronizing metabolism during entrainment to restricted feeding during the light cycle. FASEB J. 24, 862-872. doi: 10.1096/fj.09-142000
302. Svetkey, L. P., Weinberger, M. H., Gavras, H., Gavras, I., Brown, T. S., Deterding, J., et al. (1987). Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension. J. Clin. Hypertens. 3, 579-588.
303. Szczepanska-Sadowska, E., Cudnoch-Jedrzejewska, A., Ufnal, M., and Zera, T. (2010). Brain and cardiovascular diseases: common neurogenic background of cardiovascular, metabolic and inflammatory diseases. J. Physiol. Pharmacol. 61, 509-521.
304. Taddei, S., and Grassi, G. (2005). Angiotensin II as the link between nitric oxide and neuroadrenergic function. J. Hypertens. 23, 935-937. doi: 10.1097/01.hjh.0000166831.48065.06
305. Takaya, J., Iharada, A., Okihana, H., and Kaneko, K. (2013). A calcium-deficient diet in pregnant, nursing rats induces hypomethylation of specific cytosines in the 11beta-hydroxysteroid dehydrogenase-1 promoter in pup liver. Nutr. Res. 33, 961-970. doi: 10.1016/j.nutres.2013.07.015
306. Tallam, L. S., da Silva, A. A., and Hall, J. E. (2006). Melanocortin-4 receptor mediates chronic cardiovascular and metabolic actions of leptin. Hypertension 48, 58-64. doi: 10.1161/01.HYP.0000227966.36744.d9
307. Tallam, L. S., Stec, D. E., Willis, M. A., da Silva, A. A., and Hall, J. E. (2005). Melanocortin-4 receptor-deficient mice are not hypertensive or salt-sensitive despite obesity, hyperinsulinemia, and hyperleptinemia. Hypertension 46, 326-332. doi: 10.1161/01.HYP.0000175474.99326.bf
308. Tan, J., McKenzie, C., Potamitis, M., Thorburn, A. N., Mackay, C. R., and Macia, L. (2014). The role of short-chain fatty acids in health and disease. Adv. Immunol. 121, 91-119. doi: 10.1016/B978-0-12-800100-4.00003-9
309. Tellioglu, T., and Robertson, D. (2001). Genetic or acquired deficits in the norepinephrine transporter: current understanding of clinical implications. Expert Rev. Mol. Med. 2001, 1-10. doi: 10.1017/s1462399401003878
310. Teslovich, T. M., Musunuru, K., Smith, A. V., Edmondson, A. C., Stylianou, I. M., Koseki, M., et al. (2010). Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707-713. doi: 10.1038/nature09270
311. Thorleifsson, G., Walters, G. B., Gudbjartsson, D. F., Steinthorsdottir, V., Sulem, P., Helgadottir, A., et al. (2009). Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat. Genet. 41, 18-24. doi: 10.1038/ng.274
312. Thorp, A. A., and Schlaich, M. P. (2015). Relevance of sympathetic nervous system activation in obesity and metabolic syndrome. J. Diabetes Res. 2015:341583. doi: 10.1155/2015/341583
313. Thorsell, A. (2010). Brain neuropeptide Y and corticotropin-releasing hormone in mediating stress and anxiety. Exp. Biol. Med. (Maywood) 235, 1163-1167. doi: 10.1258/ebm.2010.009331
314. Thundyil, J., Pavlovski, D., Sobey, C. G., and Arumugam, T. V. (2012). Adiponectin receptor signalling in the brain. Br. J. Pharmacol. 165, 313-327. doi: 10.1111/j.1476-5381.2011.01560.x
315. Tilg, H., and Moschen, A. R. (2006). Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 6, 772-783. doi: 10.1038/nri1937
316. Toperoff, G., Kark, J. D., Aran, D., Nassar, H., Ahmad, W. A., Sinnreich, R., et al. (2015). Premature aging of leukocyte DNA methylation is associated with type 2 diabetes prevalence. Clin. Epigenetics 7, 35. doi: 10.1186/s13148-015-0069-1
317. Touvier, T., Conte-Auriol, F., Briand, O., Cudejko, C., Paumelle, R., Caron, S., et al. (2009). LEPROT and LEPROTL1 cooperatively decrease hepatic growth hormone action in mice. J. Clin. Invest. 119, 3830-3838. doi: 10.1172/JCI34997
318. Tracey, K. J. (2002). The inflammatory reflex. Nature 420, 853-859. doi: 10.1038/nature01321
319. Tracey, K. J. (2007). Physiology and immunology of the cholinergic antiinflammatory pathway. J. Clin. Invest. 117, 289-296. doi: 10.1172/JCI30555
320. Tracey, K. J. (2009). Reflex control of immunity. Nat. Rev. Immunol. 9, 418-428. doi: 10.1038/nri2566
321. Trakhtenberg, E. F., and Goldberg, J. L. (2011). Neuroimmune communication. Science 334, 47-48. doi: 10.1126/science.1213099
322. Turek, F. W., Joshu, C., Kohsaka, A., Lin, E., Ivanova, G., McDearmon, E., et al. (2005). Obesity and metabolic syndrome in circadian Clock mutant mice. Science 308, 1043-1045. doi: 10.1126/science.1108750
323. van Dijk, S. J., Molloy, P. L., Varinli, H., Morrison, J. L., Muhlhausler, B. S., and Members of Epi, S. (2015). Epigenetics and human obesity. Int. J. Obes. (Lond.) 39, 85-97. doi: 10.1038/ijo.2014.34
324. van Himbergen, T. M., Beiser, A. S., Ai, M., Seshadri, S., Otokozawa, S., Au, R., et al. (2012). Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and Alzheimer disease: results from the Framingham Heart Study. Arch. Neurol. 69, 594-600. doi: 10.1001/archneurol.2011.670
325. Van Kaer, L., Parekh, V. V., and Wu, L. (2013). Invariant natural killer T cells as sensors and managers of inflammation. Trends Immunol. 34, 50-58. doi: 10.1016/j.it.2012.08.009
326. Van Leusden, J. W., Sellaro, R., and Colzato, L. S. (2015). Transcutaneous Vagal Nerve Stimulation (tVNS): a new neuromodulation tool in healthy humans? Front. Psychol. 6:102. doi: 10.3389/fpsyg.2015.00102
327. Vink, T., Hinney, A., van Elburg, A. A., van Goozen, S. H., Sandkuijl, L. A., Sinke, R. J., et al. (2001). Association between an agouti-related protein gene polymorphism and anorexia nervosa. Mol. Psychiatry 6, 325-328. doi: 10.1038/sj.mp.4000854
328. Vinnikov, I. A., Hajdukiewicz, K., Reymann, J., Beneke, J., Czajkowski, R., Roth, L. C., et al. (2014). Hypothalamic miR-103 protects from hyperphagic obesity in mice. J. Neurosci. 34, 10659-10674. doi: 10.1523/JNEUROSCI.4251-13.2014
329. Vogelzangs, N., Suthers, K., Ferrucci, L., Simonsick, E. M., Ble, A., Schrager, M., et al. (2007). Hypercortisolemic depression is associated with the metabolic syndrome in late-life. Psychoneuroendocrinology 32, 151-159. doi: 10.1016/j.psyneuen.2006.11.009
330. Voisin, S., Almén, M. S., Zheleznyakova, G. Y., Lundberg, L., Zarei, S., Castillo, S., et al. (2015). Many obesity-associated SNPs strongly associate with DNA methylation changes at proximal promoters and enhancers. Genome Med. 7, 103. doi: 10.1186/s13073-015-0225-4
331. Volek, J. S., and Feinman, R. D. (2005). Carbohydrate restriction improves the features of metabolic syndrome. metabolic syndrome may be defined by the response to carbohydrate restriction. Nutr. Metab. (Lond.) 2:31. doi: 10.1186/1743-7075-2-31
332. Volek, J. S., Sharman, M. J., and Forsythe, C. E. (2005). Modification of lipoproteins by very low-carbohydrate diets. J. Nutr. 135, 1339-1342.
333. Wabitsch, M., Funcke, J. B., Lennerz, B., Kuhnle-Krahl, U., Lahr, G., Debatin, K. M., et al. (2015). Biologically inactive leptin and early-onset extreme obesity. N. Engl. J. Med. 372, 48-54. doi: 10.1056/NEJMoa1406653
334. Wake, D. J., and Walker, B. R. (2006). Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 in obesity. Endocrine 29, 101-108. doi: 10.1385/ENDO:29:1:101
335. Wake, D. J., Homer, N. Z., Andrew, R., and Walker, B. R. (2006). Acute in vivo regulation of 11beta-hydroxysteroid dehydrogenase type 1 activity by insulin and intralipid infusions in humans. J. Clin. Endocrinol. Metab. 91, 4682-4688. doi: 10.1210/jc.2006-0819
336. Walley, A. J., Asher, J. E., and Froguel, P. (2009). The genetic contribution to non-syndromic human obesity. Nat. Rev. Genet. 10, 431-442. doi: 10.1038/nrg2594
337. Wang, L., Opland, D., Tsai, S., Luk, C. T., Schroer, S. A., Allison, M. B., et al. (2014). Pten deletion in RIP-Cre neurons protects against type 2 diabetes by activating the anti-inflammatory reflex. Nat. Med. 20, 484-492. doi: 10.1038/nm.3527
338. Wang, L., Rao, F., Zhang, K., Mahata, M., Rodriguez-Flores, J. L., Fung, M. M., et al. (2009). Neuropeptide Y(1) Receptor NPY1R discovery of naturally occurring human genetic variants governing gene expression in cella as well as pleiotropic effects on autonomic activity and blood pressure in vivo. J. Am. Coll. Cardiol. 54, 944-954. doi: 10.1016/j.jacc.2009.05.035
339. Wang, M. (2005). The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome. Nutr. Metab. (Lond.) 2:3. doi: 10.1186/1743-7075-2-3
340. Wang, X., Lacza, Z., Sun, Y. E., and Han, W. (2014). Leptin resistance and obesity in mice with deletion of methyl-CpG-binding protein 2 (MeCP2) in hypothalamic pro-opiomelanocortin (POMC) neurons. Diabetologia 57, 236-245. doi: 10.1007/s00125-013-3072-0
341. Wegner, M., Neddermann, D., Piorunska-Stolzmann, M., and Jagodzinski, P. P. (2014). Role of epigenetic mechanisms in the development of chronic complications of diabetes. Diabetes Res. Clin. Pract. 105, 164-175. doi: 10.1016/j.diabres.2014.03.019
342. Wei, S. G., Zhang, Z. H., Beltz, T. G., Yu, Y., Johnson, A. K., and Felder, R. B. (2013). Subfornical organ mediates sympathetic and hemodynamic responses to blood-borne proinflammatory cytokines. Hypertension 62, 118-125. doi: 10.1161/HYPERTENSIONAHA.113.01404
343. Wei, Z., Zhang, K., Wen, G., Balasubramanian, K., Shih, P. A., Rao, F., et al. (2013). Heredity and cardiometabolic risk: naturally occurring polymorphisms in the human neuropeptide Y(2) receptor promoter disrupt multiple transcriptional response motifs. J. Hypertens. 31, 123-133. doi: 10.1097/HJH.0b013e32835b053d
344. Westman, E. C., Feinman, R. D., Mavropoulos, J. C., Vernon, M. C., Volek, J. S., Wortman, J. A., et al. (2007). Low-carbohydrate nutrition and metabolism. Am. J. Clin. Nutr. 86, 276-284.
345. Willer, C. J., Speliotes, E. K., Loos, R. J., Li, S., Lindgren, C. M., Heid, I. M., et al. (2009). Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat. Genet. 41, 25-34. doi: 10.1038/ng.287
346. Winer, D. A., Luck, H., Tsai, S., and Winer, S. (2016). The intestinal immune system in obesity and insulin resistance. Cell Metab. 23, 413-426. doi: 10.1016/j.cmet.2016.01.003
347. Wolf, E. J., Mitchell, K. S., Logue, M. W., Baldwin, C. T., Reardon, A. F., Humphries, D. E., et al. (2013). Corticotropin releasing hormone receptor 2 (CRHR-2) gene is associated with decreased risk and severity of posttraumatic stress disorder in women. Depress. Anxiety 30, 1161-1169. doi: 10.1002/da.22176
348. Wu, Y., Patchev, A. V., Daniel, G., Almeida, O. F., and Spengler, D. (2014). Early-life stress reduces DNA methylation of the Pomc gene in male mice. Endocrinology 155, 1751-1762. doi: 10.1210/en.2013-1868
349. Xiao, E., Xia-Zhang, L., Vulliémoz, N. R., Ferin, M., and Wardlaw, S. L. (2003). Agouti-related protein stimulates the hypothalamic-pituitary-adrenal (HPA) axis and enhances the HPA response to interleukin-1 in the primate. Endocrinology 144, 1736-1741. doi: 10.1210/en.2002-220013
350. Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., et al. (2003). Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423, 762-769. doi: 10.1038/nature01705
351. Yang, M., Xu, Y., Liang, L., Fu, J., Xiong, F., Liu, G., et al. (2014). The effects of genetic variation in FTO rs9939609 on obesity and dietary preferences in Chinese Han children and adolescents. PLoS ONE 9:e104574. doi: 10.1371/journal.pone.0104574
352. Young, C. N., and Davisson, R. L. (2015). Angiotensin-II, the brain, and hypertension: an update. Hypertension 66, 920-926. doi: 10.1161/HYPERTENSIONAHA.115.03624
353. Young, C. N., Li, A., Dong, F. N., Horwath, J. A., Clark, C. G., and Davisson, R. L. (2015). Endoplasmic reticulum and oxidant stress mediate nuclear factor-kappaB activation in the subfornical organ during angiotensin II hypertension. Am. J. Physiol. Cell Physiol. 308, C803-C812. doi: 10.1152/ajpcell.00223.2014
354. Young, C. N., Morgan, D. A., Butler, S. D., Mark, A. L., and Davisson, R. L. (2013). The brain subfornical organ mediates leptin-induced increases in renal sympathetic activity but not its metabolic effects. Hypertension 61, 737-744. doi: 10.1161/HYPERTENSIONAHA.111.00405
355. Yuan, B., and Teng, J. F. (2014). Association between adiponectin receptor 2 gene polymorphisms and cerebral infarction. Genet. Mol. Res. 13, 7808-7814. doi: 10.4238/2014.September.26.19
356. Zeng, W., Pirzgalska, R. M., Pereira, M. M., Kubasova, N., Barateiro, A., Seixas, E., et al. (2015). Sympathetic neuro-adipose connections mediate leptin-driven lipolysis. Cell 163, 84-94. doi: 10.1016/j.cell.2015.08.055
357. Zhang, J. V., Ren, P. G., Avsian-Kretchmer, O., Luo, C. W., Rauch, R., Klein, C., et al. (2005). Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 310, 996-999. doi: 10.1126/science.1117255
358. Zhang, N., Lin, J. K., Chen, J., Liu, X. F., Liu, J. L., Luo, H. S., et al. (2013). MicroRNA 375 mediates the signaling pathway of corticotropin-releasing factor (CRF) regulating pro-opiomelanocortin (POMC) expression by targeting mitogen-activated protein kinase 8. J. Biol. Chem. 288, 10361-10373. doi: 10.1074/jbc. M112.425504
359. Zhang, X., Yang, R., Jia, Y., Cai, D., Zhou, B., Qu, X., et al. (2014). Hypermethylation of Sp1 binding site suppresses hypothalamic POMC in neonates and may contribute to metabolic disorders in adults: impact of maternal dietary CLAs. Diabetes 63, 1475-1487. doi: 10.2337/db13-1221
360. Zhang, Z. H., Wei, S. G., Francis, J., and Felder, R. B. (2003). Cardiovascular and renal sympathetic activation by blood-borne TNF-alpha in rat: the role of central prostaglandins. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284, R916-R927. doi: 10.1152/ajpregu.00406.2002
361. Zheng, J., Xiao, X., Zhang, Q., Yu, M., Xu, J., Wang, Z., et al. (2015). Maternal and post-weaning high-fat, high-sucrose diet modulates glucose homeostasis and hypothalamic POMC promoter methylation in mouse offspring. Metab. Brain Dis. 30, 1129-1137. doi: 10.1007/s11011-015-9678-9
362. Zhou, J., Xu, L., Huang, R. S., Huang, Y., Le, Y., Jiang, D., et al. (2013). Apolipoprotein A5 gene variants and the risk of coronary heart disease: a casecontrol study and metaanalysis. Mol. Med. Rep. 8, 1175-1182. doi: 10.3892/mmr.2013.1642
363. Ziegler, M. G., Elayan, H., Milic, M., Sun, P., and Gharaibeh, M. (2012). Epinephrine and the metabolic syndrome. Curr. Hypertens. Rep. 14, 1-7. doi: 10.1007/s11906-011-0243-6
364. Zimmet, P., Alberti, K. G., and Shaw, J. (2001). Global and societal implications of the diabetes epidemic. Nature 414, 782-787. doi: 10.1038/414782a